



OXYGEN GRADIENTS AND EXTRACELULLAR 
MATRIX INTERACTIONS SYNERGISTIC 











A dissertation submitted to The Johns Hopkins University in conformity with the 



















© 2018 Daniel M. Lewis 







Soft tissue sarcomas are a heterogeneous group of malignant cancers derived from 
transformed cells of mesenchymal origin. Approximately 13,000 new cases per year are 
diagnosed in the US alone, with 25–50% of patients developing recurrent and metastatic 
disease. Current clinical data suggest that undifferentiated pleomorphic sarcoma (UPS) is 
one of the most aggressive sarcoma subtypes, which frequently results in lethal 
pulmonary metastases that are insensitive to radio/chemotherapy. It has recently become 
apparent that sarcoma progression and metastasis are regulated by microenvironmental 
cues such as extracellular matrix (ECM) remodeling, cell-to-cell/matrix interactions, 
signaling factors, and spatial gradients. Current hydrogel platforms to study the tumor 
microenvironment do not fully capture complexity of the tumor microenvironment. 
Addressing the need for hydrogel platforms that more closely mimic the tumor 
microenvironment, we developed a new class of hydrogels to study oxygen gradients, 
collagen architecture, as well as stress relaxation as how it effects sarcoma cell migration.    
First we utilized a novel gelatin based hydrogel to create a fast forming hypoxic 
gradient to explore the effect of varying oxygen tensions on sarcoma cell migration. To 
accurately model the effect of the O2 gradient, we examined individual sarcoma cells 
embedded in the O2-controllable hydrogel. We observed that hypoxic gradients guide 
sarcoma cell motility and matrix remodeling through hypoxia inducible factor one alpha 
(HIF–1α)  activation. We further found that in the three-dimensional hypoxic gradient, 
individual cells migrate quicker, across longer distances, and in the direction of 




sarcoma metastasis, abrogated cell migration and matrix remodeling in the hypoxic 
gradient. To determine the impact of collagen fiber density and hypoxic gradient on 
sarcoma cell migration, we then generated hypoxic collagen gels. Sarcoma cells 
encapsulated in high fiber density hypoxic gels migrated faster and degraded the matrix 
more rapidly compared to the low fiber density hypoxic constructs. Finally, we explored 
the effect of stress relaxation in the hypoxic collagen platform. From this study we can 
conclude that a quicker stress relaxation in hypoxic gradients lead to an increase in cell 
migration due to an increase procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2) 
expression. We determined the quicker stress relaxation increases PLOD2 via 
transforming growth factor beta (TGF-). Indeed, In-vivo we found an increase in tumor 
growth in the quicker stress relaxation hydrogels as well as an increase in collagen 
secretion and PLDO2 expression. Analyzing data from the cancer genome atlas (TCGA), 
we found a significant decrease in patient survival with an increase in PLOD2. Finally, 
when sarcoma from primary patient tissue was encapsulated in the system the cells 
demonstrated the same predicted phenotype as the mouse sarcoma line. 
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1.1 Physiochemical Properties of the Tumor Microenvironment 
In developing new cancer therapeutics there has been a great motivation to develop 
in-vitro platforms to better screen novel treatments. The NIH has estimated that in the 
year of 2016, 1.68 million people will be diagnosed with cancer with 595,690 people 
estimated to die of cancer[1]. The average cost of a new therapy is around $2.6 billion[2]. 
One of  major factors of these costs in the cost of  research and development, and the 
extensive amount of animal testing necessary to comply with FDA guidelines. In addition 
to the costs, these therapies also have a high failure rate due to current in-vitro and even 
in-vivo models that are unable to predict efficacy and effects of therapies in humans. 
Currently there is a 12% success rates for a drug to complete all stages of clinical trials, 
with most drugs failing in phase 2 clinical trials at a rate of 67%[3]. As such, there is a 
need to better understand the mechanism of action of potential target of therapeutics and 
to better predict treatment outcomes of such potential therapeutics. Toward this, a better 
understanding of the cancer microenvironment needs to be established, to enable the 
development of research tools that more accurately portray the patho-physiological 
aspects of the tumor and its surroundings. Moreover, such research and development 
tools could potentially be used for diagnostic applications. The average cost of a cancer 




at $91 billion dollars[4].  In addition, many patients have to go through multiple rounds 
of treatment without in order to have their cancer eradicated. Thus, the technologies 
developed to better mimic the tumor microenvironment (TME) to study and screen 
potential therapeutics, can be adapted for diagnostic and preventive applications.   
The tumor microenvironment is a intricate and dynamic milieu containing 
supporting cells, blood vessels and extracellular matrix  (ECM) proteins. In addition, 
there is a complex combination of chemical, mechanical and physical cues that regulate 
cancer progression such as stiffness of the ECM, pressure of the growing tumor mass, 
secreted and sequestrated cytokines/growth factors, oxygen, pH, and glucose 
concentration. All of these cues contribute to the decision of cancer cells to grow or 
migrate. These environmental cues are typically present in a three-dimensional 
environment. This system is drastically different than conventional two-dimensional 
culture regimes used to study mechanisms that regulate cancer growth. These in vitro 
two-dimensional culture regimes have minimal physiological relevance, as they do not 
accurately portray the complexity of the tumor environment. As a result, current studies 
using two-dimensional culture regimes have shown limited translational impact as well as 
a low screening ability for successful therapies.  
One approach could be to develop biomaterials and hydrogel technologies that 
mimic the cancer microenvironment in the three-dimension. Hydrogels are cross-linked 
polymeric networks that are extensively swollen with water[5]. These polymer networks 
can be made up of a wide variety of materials such as natural, synthetic, or a 
natural/synthetic hybrid[6]. Hydrogel properties such as stiffness, cell adhesion domains, 




platforms can be applied to study mechanisms underlying cancer development, growth 
and metastasis, as well as to screen cancer therapeutics. Towards the design of these 
novel hydrogel materials, a better understanding of the tumor microenvironment must be 
established. 
 The native tumor microenvironment is composed of a complex structure of ECM 
proteins with varying chemical and mechanical gradients that lead to the migration and 
proliferation of cancer cells. The extracellular environment has many cues that lead to 
cancer cell migration. In the following sections we focus on key aspects in the tumor 
microenvironment that regulate cancer cell fates, including the ECM composition, matrix 
remolding, oxygen, pH, cytokines, and stiffness. 
1.1.1 Extraceullular Matrix  
The ECM is the acellular component of a tissue made of a meshwork of highly 
cross-linked proteins[8]. The ECM is made up of a wide variety of proteins, such as 
fibronectins, collagens, laminins, glycoproteins, etc.)[8]. Collagen is the most abundant 
protein in the ECM, which constitutes up to 30% of the total proteins in the body and 
90% of the ECM[9, 10] . Collagen is a substantial structural feature of the ECM that 
regulate tensile strength and cell adhesion[11]. Collagen molecules are made up of three 
alpha helical structures that together form a fibril structure. These fibers form larger 
supramolecular structures that create the backbone of collagen bundles[10]. These fibrous 
bundles are modified through the hydroxylation of proline and lysine resides, allowing 
for the strengthening and crosslinking of collagen fibers[12]. Another major ECM 
component is fibronectin. Fibronectin is made from a dimer that is joined by c-terminal 




integrin receptors[13]. Laminin is another crucial ECM protein. This molecule is crucial 
for cell attachment to the matrix[14]. Laminin has been shown to increase migration in 
breast carcinomas[15, 16]. All of these proteins in conjunction create a fibrillar network. 
This fibrillar network morphology can be imaged using second harmonic generation 
(SHG) microscopy [17]. SHG microscopy is a process where two photons are up-
converted to half of the wavelength of the excitation laser. These lasers when funneled 
through polarized optics allow for a detailed structure of collagen to be produced. [18].  
Within the ECM there are cancer-associated fibroblasts (CAFs), which have been 
shown to modify the ECM, leading to fibrillar ECM[19]. Specifically, CAFs have been 
shown to contribute to the synthesis of type I, type III, and type IV collagen, fibronectin 
and laminin[20-22]. It has been shown that increased number of fibroblasts leads to an 
increase in type I collagen deposition. These fibroblasts lead to an higher deposition of 
ECM as well as remodeling of the matrix. All of these factors lead to a higher chance of 
tumorgenesis.[23]. 
1.1.2 Matrix Remodeling 
CAF’s as well as cancer cells secrete a wide variety of proteases and ECM 
modifiers. Two of the most studied enzymes are matrix metalloproteinase (MMP) and 
thrombospondin motifs (ADAMTS), which specialize in degrading the ECM[23]. There 
are about 23 members in the MMP family[24]. MMPs target a large range of extracellular 
proteins, including MMP-1 that targets collagen, MMP-2 that targets gelatin (denatured 
collagen), and MMP-7 that targets fibronectin[25, 26]. These MMP’s have  two 
classifications: soluble (secreted)-type and membrane-anchored MMPs[27, 28]. Soluble 




the soluble MMP’s resides a cysteine residue which ligates catalytic zinc[29]. This 
cysteine-zinc interaction is disrupted in a two-step reaction. The reaction starts by 
cleaving the pro-peptide region to remove the n-terminal polypeptide. The second step 
occurs through an auto-proteolytic reaction, which generates an active enzyme[30]. 
Membrane-type (MT)-MMP are anchored to the membrane and are activated by pro-
protein convertases[28]. ADAMTS share a similar structure to MMPs in which they both 
have pro-domains that needs to be activated, degrading the surrounding matrix. The 
difference between MMPs and ADMATS is that instead of a cytosine rich domain, 
ADMATS have a thrombospondin domain[31].  
Besides matrix degradation, cancer cells modify the ECM to facilitate migration. 
Because of the prevalence of interstitial collagen in the tumor microenvironment, it is 
subject to a large number of posttranslational modifications[32]. Collagen crosslinking is 
primarily mediated by lysyl oxidase (LOX) and LOX-like enzymes. The LOX 
crosslinking has been shown to increase cancer cell migration as well as increase ECM 
stiffness[33, 34]. Baker et al, have shown that this increase in stiffness due to LOX 
crosslinking lead to an increased in colorectal cancer migration[35]. In breast cancer, it 
has been shown that LOX crosslinking induces β1 integrin clustering, PI3K signaling and 
focal adhesions[36]. Another key collagen modifier is pro-collagen-lysine, 2-oxoglutarate 
5-dioxygenase (PLOD2), which initiates lysine hydroxylation of collagen[37-39].  These 
crosslinks are crucial in the formation of mature collagen fibers, are regulated by 






1.1.3 O2 and pH  
Oxygen and pH are two important cues that regulate normal cell growth. These 
factors have lead to changes cancer cell growth to migration[42, 43]. The relative 
distance to a blood vessel determines oxygen tension and pH in the tumor 
microenvironment. Datta et al show when the tumor vasculature is re-established due to 
anti-vascular endothelial growth factor (VEGF) therapy they can observe the change in 
the oxygen and pH gradients around the tumor[44]. This therapy and similar therapies 
have been shown to effect tumor vascular, which will be discussed later in the review. 
However, as the distance from the blood vessel to the tumor increases, there is a decrease 
in oxygen concentration to levels bellow 2% oxygen, known as hypoxia[45].  Oxygen 
concentration is mediated by the distance that a tumor mass is away from a blood vessel. 
When a tumor is approximately ~200 μm away from a blood vessel which leads to 
hypoxia and server hypoxia [46]. Hypoxia has been shown to lead to increase in 
angiogenesis[47], metastatic potential[48, 49], DNA replication[49, 50], and reduced 
protein synthesis[51]. The oxygen sensing mechanism has been identified to be linked to 
transcription factor termed hypoxia inducible factor (HIF). HIF are made up of an α and β 
subunit[52]. HIF1 is accumulated at 1% oxygen[53] and rapidly degraded at 21%. There 
are three types of HIFs; HIF1, HIF2, and HIF3. The main difference between these 
factors is that HIF1α is constantly expressed ubiquitously in most tissues, while HIF2α 
and HIF 3α are found in a subset of tissues[54-56]. Hypoxia in general leads to up 
regulation of a variety of factors (Figure 1-1), from pro-angiogenic to ECM modifiers for 
example collagen remodeling genes such as PLOD2 and LOX to angiogenic and 




cells exposed to hypoxia are usually far away from blood vessels, and therefore less 
exposed to drugs, as well as lower proliferation rates and less sensitivity to radiotherapy 
and p53-mediated apoptosis[58]. Recently our lab has developed a platform to better 
screen potential cancer therapeutics in a hypoxic cancer tumor microenvironment[59]. 
 





Modified from Reference 46. Abbreviations: ALDA, aldolase A; ANG-1, 
angiopoietin 1; ANG-2, angiopoietin 2; BMDSC, bone marrow derived stem cell;  
CCND1, cyclin D1; CTGF, connective tissue growth factor; CXCR4, C-X-C 
chemokine receptor type 4; ECM, extracellular matrix;  ENO1, enolase 1; EPO, 
erythropoietin; FLK-1, VEGF receptor 2; FLT-1, VEGF receptor 1; GLUT, glucose 
transporter; HIF, hypoxia-inducible factor; HK, hexokinase; IGF-2, insulin growth 
factor-2; IGF-BP2, IGF-factor-binding protein 2; LDH-A, lactate dehydrogenase A; 
LOX, lysyl oxidase; miRNA, micro-RNA; LOXL, lysyl oxidase homolog 1;  MMP, 
matrix metalloproteinase; MXI-1, max interactor 1; P4HA, Prolyl 4-hydroxylase 
subunit alpha-1; PAI-1, plasminogen activator inhibitor-1; PDGF-B, platelet-
derived growth factor-B; PDK1, pyruvate dehydrogenase kinase 1; PFKL, 
phosphofructokinase L; PGK1, phosphoglycerate kinase 1; PLOD, procollagen-
lysine 2-oxoglutarate 5-dioxygenase; SDF-1, stromal-derived factor 1; TF, 
transcription factors; TGF-a, transforming growth factor-a; TIE-2, angiopoietin 
receptor 2; UPAR, urokinase plasminogen activator receptor; VEGF, vascular 
endothelial growth factor 
In addition to an up regulation of many cytokines, hypoxia also affects the 
metabolism of the cell. The normal metabolism and generation of adenosine triphosphate 
(ATP) is highly sensitive to oxygen concentration. It has been shown that hypoxia causes 
a substantial decrease in ATP production[60]. Normally, cancer cells have to change their 
metabolism to rapidly produce ATP[61]. Under hypoxia, cancer cells switch from their 
normal oxidative phosphorylation to glycolysis. In order to maintain the high levels of 
ATP, these cells drastically increase their glucose uptake to maintain the ATP level. By 
using glycolysis, cancer cells can very quickly generate ATP even faster then 
conventional oxidative phosphorylation. However, due to this type of metabolism, the pH 
in extracellular environment drops from a physiological pH of 7.2 to an acidic 
microenvironment to a pH between 5.6-6.8[46]. 
1.1.4 Stiffness  
Stiffness of the ECM is a crucial characteristic of the tumor microenvironment, 
with the majority of the ECM made out of collagen 1. As detailed above, the density of 




regulation of crosslinkers by the CAFs and cancer cells. In fact, an increase in collagen 
crosslinkers such as LOX and PLOD2 have been shown to lead to facilitate tumor 
progression[62]. Because of this increase in LOX secretion cancer cells have responded 
by clustering non-receptor tyrosine kinases, specifically focal adhesion kinase (FAK). 
Paszek et al have shown that 3D matrices with a Young’s modulus of 400 Pa to have a 
significant increase in the size of colonies compared to colonies cultured in 3D matrices 
with a Young’s modulus of 160-170 Pa[33]. They linked this increase in size to 
clustering of α5β1-integrin, which caused stimulation of FAK phosphorylation, RhoA 
activity and cytoskeletal contractility.  
 In addition to stiffness, another factor of the tumor microenvironment that 
plays a roll the pore size of the surrounding matrix. Patheck et all have shown how ECM 
matrix stiffness and confinement play a role in cancer cell migration, demonstrating that 
cells in stiffer and narrower channels migrating faster[63]. Haeger et al explored this 
concept of confinement and cell-cell junctions in collagen gels[64]. They concluded that 
depending on the type and density of the ECM the mode of migration changes, with cells 
in denser matrixes have a “follow the leader” type migration, while in less porous 
matrixes, single cell migration was observed. The ECM stiffness has also been shown to 
increase the differentiation of epithelial cancer cells to a more mesenchymal phenotype. 
Wei et al recently published that nuclear translocation of TWIST1, leads to an increase in 
mesenchymal transition via this mechano-transduction pathway[65]. 
1.1.5 Stress Relaxation  
In addition to ECM stiffness, another mechanical property of the ECM that is recently 




constant strain. When the stress relaxation modulus decreases that is similar as having a 
lower resistance to deformation over time. Recently, it has been shown that different 
organs have different stress relaxation times[66]. Different stress relaxation times were 
also reported in different tumor types[67]. Previous work has examined the effect of 
stress relaxation on cell behavior[68-71]. Stress relaxation has been shown to affect 
including cell motility[72], mesenchymal stem cell differentiation [66], and the cell’s 
ECM sensing capability [73]. 
1.2 Polymeric Hydrogels as Engineering Three-Dimensional 
Microenvironments 
Polymeric Polymeric hydrogels, which are composed of a three-dimensional (3D) 
hydrophilic network, have been recognized as a promising material for regenerative 
medicine and pharmacological applications due to their multi-tunable properties and 
structural similarity to the native extracellular matrices (ECMs).[74-79] Their physico-
chemical and biological properties, such as mechanical strength, degradation behavior, 
nutrient transport, and spatiotemporal topography, can be regulated by the types of 
polymers and their compositions, crosslinking density, and tailoring with various 
bioactive molecules (i.e cell adhesion ligands, proteolytic degradation sites, etc). In 
addition, these matrices are utilized as artificial cellular microenvironments for 
recapitulating ECMs in soft tissues due to their high swelling properties and mechanical 
resemblance. In particular, in situ crosslinkable hydrogels, which show phase transition 
from solution to gel through various crosslinking chemistries, have attracted substantial 
attention as engineered cellular microenvironments and drug delivery carriers owing to 




as well as minimally invasive properties.[80-82] With advances in materials engineering, 
various in situ forming hydrogels and crosslinking strategies have been developed to 
create engineered microenvironments for supporting cell growth and directing their fate 
(Figure 1-2).[83] In this section, we discuss various types of polymeric hydrogels and 







Figure 1-2: In situ cross-linakble hydrogels as an artificial cellular 
microenvironment. 
Cross-linking strategies are detailed for each hydrogel system. Abbreviations: CD-
HA, β-cyclodextrin-modified hyaluronic acid; FA, ferulic acid; GelMA, 
methacrylated gelatin; GtnFA, gelatin grafted with ferulic acid; HA, hyaluronic 
acid; MMP, matrix metalloproteinase; PEG, poly(ethylene glycol); PEG-diNHS, 






1.2.1 Natural Hydrogel Materials  
Collagen type I is a well-known ECM protein that provides structural frame to 
support cell growth and adhesion through cell-to-cell and cell-to-matrix interaction since 
it has various binding sites that interact to cell-surface receptors and to other ECM 
components (e.g., fibronectin).[84, 85] It also includes proteolytic degradable sites for 
ECM remodeling within cellular microenvironments, which is a critical parameter for 
regulating cell behaviors in the microenvironments.[84] Generally, collagen hydrogels 
are prepared via physical crosslinking by pH and temperature-sensitivity, which can 3D 
fibrillar matrices recapitulating the ECMs in vivo. Increasing pH and temperature of 
acidic collagen precursor solution induces fibrilar hydrogel matrices.[86] Based on their 
unique properties, collagen has been widely used as scaffolds for tissue engineering and 
regenerative medicine as well as other biomedical applications. However, the critical 
disadvantages of collagen are the weak mechanical properties and batch-to-batch 
variation. To improve these limitations, many chemical crosslinking methods have been 
developed, including chemical glycation[87] and enzyme-mediated crosslinking 
reaction[88] to give more stable and stiff collagen hydrogels through chemical 
crosslinking. For example, David and colleagues developed a method to fabricate 
chemically crosslinked collagen hydrogels using transglutaminase that catalyze the amide 
crosslinking from the specific functional groups (e.g., γ-carboxamide and primary amine 
in collagen chains).[88] Using this approach, they fabricated more stable collagen 
hydrogels compared to physically crosslinked collagen hydrogels. Baoxing and 
colleagues utilized a different crosslinking condition using genipin that an excellent 




The mechanical properties can be controlled by varying genipin concentrations, showing 
from 2 to 50 kPa of compressive strength. However, this system has a disadvantage such 
as slow chemical reaction (over 24 h to fully cross-link the networks). More recently, 
Hyunjoon and his colleagues developed a novel strategy to create more stable and multi-
tunable collagen hydrogels using poly(ethylene glycol) conjugated with di-(succinic acid 
N-hydroxysuccinimidly ester) (PEG-diNHS) that induce interconnection between 
collagen fibers through crosslinking of primary amines in polymer backbones.[90] Using 
the engineered collagen hydrogels, they investigated the effect of matric stiffness on the 
behaviors of cancer spheroids of hepatocarcinoma cells (HCCs). While many approaches 
have been developed to enhance the stability of collagen matrices, advanced engineering 
technologies are still required to improve cyto-compatibility and multi-tunable properties. 
Fibrin has been widely used in a wide range of biomedical applications due to 
their biocompatibility and biodegradability as well as easy to fabrication.[91] Fibrin 
hydrogels were fabricated by the crosslinking of fibrinogens through thrombin-mediated 
ionic interactions.[92, 93] In this reaction, thrombin cleaves the N-terminal end of 
fibrinogen that can induce polymerization of fibrin into fibrous hydrogel matrices.[92, 
93] These fibrin matrices also possesses various cellular responsible domains, including 
integrin, heparin, and fibronectin binding sites that are critical in regulating cellular 
activities in wound healing and tissue regeneration.[94] Based on their unique properties, 
fibrin gels have been widely utilized as either therapeutic implants or vehicles for 
regenerative medicine and drug delivery carriers as well as clinical treatments. Compared 
to collagen hydrogel, fibrin gels showed relatively higher and broader range of matrix 




concentrations. However, the fibrin gels have a problem with fast degradation of 
hydrogel matrices through tissue factors and other enzymes secreted by the cells, which is 
difficult to fully support cell growth and activities. Therefore, many studies have been 
reported to improve matrix stability of fibrin gels, allowing long-term cell culture to fully 
understand of the effect of 3D matrices on cellular activities. The representative strategy 
is to incorporate functionalized PEG as a crosslinker, defined as PEGylations. Francesca 
et al. utilized PEG-fibrin hydrogels to provide artificial tumor microenvironments for 
cancer researches.[95] They prepared PEGylated fibrin hydrogels by simple mixing of 
fibrinogen and functionalized PEG that can induce crosslinking between the polymer 
backbones through chemical reactions. Using the stable matrices, they investigated the 
effect of 3D microenvironments on the cancer cell growth (e.g., lung adenocarcinoma 
cell lines, A549 and H1299) for day 18, resulting the 3D matrices showed similar tumor 
growth compared to in vivo models. 
1.2.2  Synthetic Hydrogel Matrices  
Synthetic polymers have several advantages compared to natural polymers, such 
as more controllable physicochemical properties. Among these, Poly(ethylene glycol) 
(PEG) is well known as the representative biomaterial for medical uses. PEG is a bio-
inert and hydrophilic polymer, thus used as surface grafting materials to create anti-
fouling surfaces of biomaterials and as coating materials to enhance lubricity of medical 
catheters. In addition, PEG hydrogels are commercially used as clinical tissue sealants. 
Furthermore, a PEG has been utilized as hydrogel matrices for tissue regeneration and 
drug delivery systems due to its biocompatibility and multi-tunable properties. However, 




sensitive moieties) to support cell growth within 3D microenvironments. The most 
common strategy is to fabricate PEG hydrogels through photo-polymerization of 
diacrylated-PEG (PEGDA) chains.[96] During hydrogel formation, the bioactive 
molecules can be incorporated within the matrices. Anseth and her colleagues utilized the 
photo-curable PEG hydrogels as a template to study the effect of mechanical memory on 
stem cell fate, demonstrating stem cells have mechanical memory that stores information 
from past phsico-chemical conditions and regulates their fate.[97] There are many other 
approaches to create PEG hydrogels, including Michael-type additionreaction, thiol-ene 
reaction, and enzyme-mediated crosslinking reactions. Lutolf et al. developed a PEG 
hydrogels incorporating cysteine coligopeptides via Michael-type additions.[98] The 
conjugative reaction occurs under mild conditions, which is critical for in vitro and in 
vivo applications. Segura and her colleagues developed the similar PEG hydrogels 
through thiol-maleimide Michael-type addition using zinc (Zn), demonstrating multi-
tunable properties of the hydrogel matrices, such as kinetics of hydrogel formation and 
matrix stiffness.[99] Using the matrix, they investigated the impact of matric stiffness on 
cellular activities of human dermal fibroblasts (HDFs). 
1.2.3 Semi-Synthetic Hydrogels 
While the natural and synthetic hydrogels have been widely used as 3D matrices 
in tissue engineering and regenerative medicine, there are some limitations to be 
improved, such as matrix stability; batch-to-batch variation; accurately mimicking native 
extracellular matrices. To overcome these limitations, chemically modified natural 




approaches to create the engineered polymeric hydrogels for tissue engineering and 
regenerative medicine. 
Alginate is a naturally derived anionic polymer, which is composed of the 
repeating units of (1-4)-linked β-D-mannurinate (M units) and α-L-gluronate (G 
units).[100] Alginate hydrogels forms in the presence of divalent cations (e.g., Ca++ and 
Mg++) through ionic interaction between the G units in the polymer backbones. Due to 
its biocompatibility and easy fabrication process, alginate hydrogels have been used in 
various clinical applications, including wound dressing, drug delivery, and tissue 
regeneration as well as treatments of myocardial infraction.[101, 102] While it is useful 
in various biomedical applications, it remains a challenge to improve its mechanical 
properties and bioactivity. To improve these limitations, many research have been 
endeavored to introduce chemical modifications of alginate chains. Dhoot et al. have 
conjugated cell adhesive sites (Arg-Gly-Asp, RGD) into alginate chains to enhance 
cellular activities.[103] Zhu and colleagues have developed an enzymatically crosslinked 
alginate hydrogels, which is composed of tyramine-conjugated alginate that can form 
chemically cross-linked hydrogels through horseradish peroxidase (HRP)-mediated 
oxidative reaction.[104] More recently, Mooney and his colleagues developed a novel 
strategy to create highly stretchable and tough alginate hydrogels through the formation 
of interpenetrating networks (IPNs).[105] To improve mechanical stiffness and hydrogel 
stability, they fabricated the hydrogels by hybridization of ionically crosslinked alginate 
networks using Ca++ and photocrosslinkable polyacrylamide gels, resulting in highly 




hydrogels with biological activities are promising materials to provide 3D matrices in 
tissue regeneration and other clinical applications.  
Gelatin, denatured collagen type I, has been widely used in tissue engineering and 
regenerative medicine due to its desirable features, including biocompatibility, 
biodegradability, cost effect, and easy to fabrication (reviewed by Barbara et al.[106]). In 
addition, it has a cellular responsive sites, such as integrin biding sites and proteolytically 
degradable domains that plays a critical roles in regulating cellular activities within 3D 
microenvironments.[107] To utilize gelatin as a biomaterial, it is required to introduce 
chemical crosslinking of polymer backbone to create stable gelatin matrices at body 
temperature. There are various ways to form a covalently crosslinked gelatin networks, 
including enzyme-mediated crosslinking and photo-crosslinking reactions. Using 
transglutaminase and formaldehyde, we can prepare gelatin hydrogels using unmodified 
gelatin. However, the process showed critical limitations for use in biomedical 
applications, such as slow phase transition and cytotoxicity. To improve these limitations, 
many approaches have been developed to create gelatin hydrogels using chemically 
modified gelatin. Khademhosseini and his colleagues developed methacrylated-gelatin 
(GelMA) that can form hydrogels through photo-polymerizations.[108] Using the 
bioactive hydrogels, they created various cell-laden matrices for regenerative medicine as 
well as engineered tissue models.[109-111] Recently, they also developed grapheme 
oxide (GO)-incorporated GelMA hydrogels to enhance mechanical properties through 
additional physical interaction between GO and polymer chains.[112] More recently, we 
also developed a novel gelatin hydrogel composed of gelatin-grafted with ferulic acid 




chemical crosslinking reaction.[81] In this reaction, lacase catalyzes the crosslinking of 
ferulic acid (FA) with oxygen consumption, resulting in 3D hydrogel networks through 
diFA formations. We demonstrated the oxygen-controllable hydrogels provided artificial 
hypoxic microenvironment to support enhanced vascular differentiation and tube 
formations of endothelial progenitor cells (EPCs). Using the advanced hydrogel matrices, 
we are trying to apply the engineered vasculatures to the treatment ischemic tissues and 
to utilize engineered tumor models to study cancer research. 
Hyaluronic acid (HA), an anionic linear glycosaminoglycan consisting of D-
glucuronic acid and N-acetyl-D-glucosamine, has been commonly used in clinical 
applications as soft tissue filler and Anti-adhesion adjuvants as well as various preclinical 
uses.[113, 114] While HA is very viscous solutions, it also needs chemical crosslinking 
to create stable HA matrices for in vitro and in vivo applications. HA hydrogels have 
been widely utilized as 3D cellular microenvironments to support vascular 
morphogenesis and cancer cell growth as it has several integrin biding sites (e.g., CD44 
and CD168) that play a critical role in regulating growth factor signaling.[115] However, 
there is no key cell adhesion site in the HA backbone, thus cell adhesion moiety should 
be incorporated to enhance cell binding affinity into the hydrogel matrices. In addition, 
HA does not have propetoytic degradable sites (e.g., MMP-sensitive sites) that are pivotal 
in matrix remodeling within cellular microenvironments. Therefore, we should consider 
to incorporate both cell adhesion and MMP-sensitive sites when design 3D cellular 
microenvironments using HA hydrogels. There are a lot of approaches to create the 
engineered microenvironments using HA hydrogels. Burdick and his colleagues 




They synthesized two kinds of precursor polymers, such as adamantine modified HA 
(guest macromer, Ad-HA) and β-cyclodextrin modified HA (host macromer, CD-HA). 
The HA hydrogels are rapidly formed by simple mixing of the solutions, resulting in 
physically crosslinked HA networks through guest-host bonds. They also developed a 
photo-curable HA hydrogels consisting of RGD-modified methacrylated HA 
(MeHA).[117] The functionalized HA hydrogels were formed by photo-polymerization 
and their mechanical properties and degradation behaviors could be controlled by varying 
relevant parameters (e.g., crosslinking density, polymer concentrations, degree of 
substitution of methacrylate, MMP-sensitive sites). Using the multi-tunable HA hydrogel 
matrices, they investigated the effect of matrix stiffness and degradation on stem cell fate. 
In addition to stem cell microenvironments, we also utilized the MeHA hydrogels as 3D 
microenvironments to support vascular differentiation of human pluripotent stem cell 
(PSCs)-derived early vascular cells (EVCs) to create stable engineered vasculatures.[118] 
We encapsulated the EVCs within RGD-modified MeHA hydrogels, which can mature in 
to endothelial cells (ECs) and pericytes to create matured vasculatures within 3D 
matrices. We also demonstrated that the engineered vasculatures are connected to host 
vasculatures with blood perfusion.  
 With advanced in biomaterials engineering, various polymeric hydrogels 
have been used as 3D matrices for a wide range of medical applications. While these 
engineered matrices are promising materials, well-defined 3D cellular 
microenvironments are still required to accurately recapitulate the native cellular 





1.3 Engineering the Tumor Microenvioerment 
The tumor microenvironments shows the complexity, diversity and dynamic nature, 
which play a critical role in cancer development and progression.[119, 120] Thus, many 
researches have endeavored to create artificial tumor microenvironment recapitulating the 
native tumors using various engineered biomaterials.[121] With advances in materials 
engineering, various polymeric hydrogels have been widely utilized as engineered 3D 
matrices to recapitulate the pathological tumor extracellular matrices to study basic 
cancer biology and to screen drug efficacy of anti-cancer agents for new aspects of cancer 
research.[122, 123] In this section, we discuss the most recent engineered tumor 
microenvironments for better understanding of cancer biology as well as emerging 
anticancer therapeutics.  In particular, we are focusing on modeling the tumor 
extracellular matrices to study the tumor angiogenesis, invasion and metastasis occurring 
in the native tumor microenvironments as well as drug screening of anti-cancer agents. 
1.3.1 Tuning Biomaterials to the Tumor Microenviorment   
In all of the hydrogel platforms there is needed to tune the specific environment to 
the tumor type of interest or origin for that specific type of cancer. Each tumor model the 
ECM needs to be tuned for pore size, binding sight availability, stiffness, and 
degradability. Breast cancer is the most common and deadly tumor in women in the 
world.[124] Various polymeric hydrogels have been used to study the effect of myriad 
parameters in the primary tumors on breast cancer progression, including invasion and 
metastasis as well as tumor-associated angiogenesis.[125] In addition, the engineered 




developed anti-cancer drugs for better understanding of breast cancer biology and better 
clinical outcomes in the cancer treatment.  
Kristie et al. utilized a biomimetic 3D breast cancer models using collagen 
hydrogels encapsulating multicellular spheroids (MDA-MB-231) to evaluate the anti-
cancer therapeutic effect of paclitaxel-loaded polymeric nanoparticles.[126] They 
fabricated the multicellular spheroids by culturing the cells on the top of aggarose 
hydrogels that is not available to attach the cells due to its bioinnert properties. The size 
of tumor spheroids was controlled by varying cell-seeding density, ranging from 100 to 
400 um. The cancer spheroids were encapsulated within collagen hydrogels by simple 
mixing of cell suspension and polymer solutions. Using the tumor models, they 
investigated the therapeutic efficacy of nanoparticles encapsulating paclitaxel compared 
to delivering the drug without carriers. Toward this, they loaded the drugs to the pH-
sensitive polymeric nanoparticles and treated to the tumor models. Interestingly, they 
found that the drug-combination with nanoparticles showed higher therapeutic effect 
compared to naked drug, suggesting that the engineered tumor models have a promising 
potential as a platform to evaluate drug candidates and delivery systems for a new cancer 
therapy development.  
Shoichet and her colleagues utilized HA hydrogels as a platform for studying 
breast cancer cell invasion depending on matrix stiffness, MMP-sensitivity, and 
concentration of cell adhesion sites.[127] They fabricated HA hydrogels that varied 
crosslinking density (mechanical) and ligand (chemical) densities independently for 
studying the effects of each parameter on breast cancer invasion. They noticed that soft 




compared to stiff matrices without MMP-sensitive sites, demonstrating the importance of 
matrix stiffness and cell-mediated matrix degradation to breast cancer invasion. 
Interestingly, they also demonstrated that the cell-adhesive ligand density affected on 
cancer cell proliferation rather than migration. 
Sarcomas are heterogeneous mesenchymal tumors diagnosed annually over 2,000 
people in the world. [128] Anseth and her colleagues utilized PEG-based hydrogels for 
investigating the effect of biochemical and biophysical matrix properties on fibrosarcoma 
(HT1080) migration.[129] For the study, they prepared peptide functionalized PEG 
hydrogels through thiol-ene photopolymerization that can be spatially and temporally 
patterned using standard lithographic method. Using the technique, they fabricated the 
hydrogel matrices with mechanical gradients (60 Pa to 260 Pa) and examined the effect 
of matrix adhesion at different moduli on HT1080 migration, demonstrating that the 
HT1080 motility was determined by a complex trend in which positives and negative 
matrix effects on tumor cell migration. They noticed that HT1080 on soft matrices 
showed faster and longer migration distance compared to stiff ones. In addition, they 
found that the cells tended to migrate from stiff region to soft areas. The results suggest 
that the engineered tumor models provide innovative tools for investigating several 
unresolved questions in tumor developments, including the effect of tissue interfaces on 
tumor motility and invasion. 
Glioblastoma multiforme (GBM) is the common and deadly form of brain tumor, 
which is aggressive and malignancy.[130] Various engineering approaches have been 
developed to recapitulate and model the GBM tumor microenvironments in vitro for 




developed bioengineered 3D brain tumor models to investigate the effects of matrix 
stiffness on GBM cell using PEG-based hydrogels.[132] The hydrogels were prepared 
through photo-polymerization, incorporating RGD and MMP-sensitive sites to support 
3D cell growth and matrix remodeling. In addition, HA was incorporated to mimic the 
concentration in the brain extracellular matrix. To examine the effect of matric moduli on 
GBM cell fate in 3D, they encapsulated U87 cells as a model GBM cell line in soft (1 
kPa) or stiff (26 kPa) hydrogels, mimicking the matrix stiffness of normal brain or GBM 
tissues. Interestingly, they noticed that increasing stiffness let to slower cell proliferation, 
but cells formed denser tumor spheroids as well as upregulation of matrix degradation 
factors (e.g., HA synthease 1 and MMP-1), demonstrating the stiffness modulate the 
extracellular matrix decomposition and remodeling that plays a pivotal roles in tumor 
invasion and metastasis. This bioengineered 3D hydrogel platform may provide an 
innovative 3D brain tumor model for investigating the mechanisms underlying GBM 
progression as well as evaluating the efficacy of potential drug candidates for treatment 
of GBM. 
Prostate cancer is one of the most common and diagnosed in men in the 
worldwide.[133] Many researchers have tried to elucidate molecular biology in the 
prostate cancer using advanced engineered platform.[134] Fong et al. utilized HA 
hydrogel-based 3D models using patient-derived prostate tumors for drug screening.[135] 
It is well known that the patient-derived xenograft (PDX) cells show poor cell viability in 
standard culture condition. To overcome this limitation, they encapsulated the PDX cells 
within 3D hydrogel matrices and evaluated the cell viability as well as drug efficacy. 




investigated the drug sensitivity of the 3D tumor models with different patient origin to 
docetaxel. Interestingly, they found that the 3D PDX PCa cells showed a significant 
higher drug resistance to the drug as compared to the cell lines. This result suggests that 
the primary culture system have a great potential for directly culturing patient tumor 
tissues for rapid drug screening, and thus provide an innovative platform for personalized 
cancer therapeutics. 
While prostate cancer is the most commonly diagnosed cancer in men (with 29% 
of all incident cases), ovarian cancer accounts only for 3% of all incident cancer cases in 
women per year.[136] It is challenging to model ovarian cancer that have genetically 
complexity, diverse pathology, and the unique mechanisms of metastasis. Thus, many 
studies have been reported to recreate the sophisticated ovarian cancer 
microenvironments for studying growing cancer spheroids and metastasis of ovarian 
cancer cells.[134, 137] Elke et al. developed 3D ovarian cancer models using gelMA 
hydrogels encapsulating the human epithelial ovarian cancer cell line (OV-MZ-6) derived 
from a patient.[138] They investigated the effect of matrix stiffness, matrix degradation, 
and incorporation of ECM components (laminin-411 and HA) on cancer spheroid 
formation. The matrix stiffness of hydrogels was modulated by varying the polymer 
concentrations (0.5 kPa-9.0 kPa). The medium stiffness (3.4 kPa) allowed tumor spheroid 
formation and high proliferation compared to other groups. In addition, they noticed that 
inhibition of proteolytic degradation of matrices reduced spheroids formation. They also 
found that incorporating laminin-411 and HA further facilitated spheroid growth within 




hydrogels may provide an alternative, bioengineered 3D ovarian cancer culture models in 
vitro. 
Thesis Overview 
In the field of cancer research there is a key gap in the use of novel 
biomaterials to control and mimic the tumor microenvironment. Combining 
improved biomaterials designs, with control over mass transfer in hydrogel system 
allows us to create novel approaches to study the tumor microenviorment (TME) 
and test possible new therapeutics. The overall hypothesis of this thesis is that the 
combinatory effect of oxygen and ECM on sarcoma cell migration leads to an 
increase in migration due to an increase in crosslinking. This thesis can be divided 
into three specific aims: 
Specific Aim 1: Intratumoral Oxygen Gradients Lead to Sarcoma Cell Migration. 
Toward in vitro modeling of biological events in sarcoma growth, we utilized 3D 
hydrogel scaffold that mimic the oxygen gradients commonly seen and study their effect 
on sarcoma cell migration. The study for this specific aim is presented in Chapter  Error! 
eference source not found.. 
Specific Aim 2: Collagen Fiber Architecture Regulates Hypoxic Sarcoma Cell 
Migration 
In addition to oxygen gradients there is a growing need to determine the 
architecture of the tumor microenvironment, with specific focus on collagen fiber 
features. We examined the effect of collagen fiber density and architecture on sarcoma 





Specific Aim 3: Quicker stress relaxation increases migration of sarcoma cells in 
hypoxic gradients 
Mechanical properties in the tumor microenvironment have been correlated with 
tumor progression. We studied the effect of matrix stress relaxation on  sarcoma cell 
migration, by developing a new hydrogel platform to explore stress relaxation in oxygen 
gradients. The study for this specific aim is presented in Chapter Error! Reference 






2 Overview of Experimental Methods 
 
2.1 Gelatin-Hypoxic Hydrogels 
2.1.1 Synthesis of Gelatin-Hypoxic Gels 
Gelatin (Gtn, type A from porcine skin, less than 300 bloom), laccase (lyophilized 
powder from mushroom, ≥4.0 units/mg), 3−methoxy−4−hydroxycinnamic acid (ferulic 
acid, FA), N−(3−dimethylaminopropyl)−N´−ethylcarbodiimide hydrochloride (EDC), 
N−hydroxysuccinimide (NHS), dimethyl sulfoxide (DMSO), and deuterium oxide (D2O) 
were supplied from Sigma−Aldrich (Saint Louis, MO) and used as obtained without 
purification. Dialysis membrane (molecular cutoff = 3500 Da) was purchased from 
Spectrum Laboratories (Rancho Dominguez, CA) Gelatin−based hypoxia−inducible 
(Gtn−HI) hydrogels were synthesized by carbodiimide-mediated coupling reaction as we 
previously reported[139]. Prior to polymer synthesis, we prepared a solvent by mixing 
DMSO and distilled (DI) water with 1 to 1 volume ratio. We dissolved gelatin (1.0 g) in 
50 ml of the solvent at 40 °C. FA (0.78 g, 4.0 mmol) was dissolved in 20 ml of the 
solvent and activated with EDC (0.92 g, 4.8 mmol, 1.2 eq. of carboxyl unit of FA) and 
NHS (0.64 g, 5.6 mmol, 1.4 eq. of carboxyl unit of FA) at room temperature for 15 
minutes to give amine reactive FA molecules. The activated solution was then applied to 
the Gtn solution and the conjugative chemical reaction was conducted at 40 °C. After 24 




(molecular cutoff = 3500 Da) for five days. After dialysis, we obtained GtnFA polymers 
by freeze−drying and kept the product in a refrigerator (below 4 °C) before use. As 
previously [139], the chemical structure was confirmed using a 1H NMR spectrometer 
(Bruker AMX−300 NMR spectrometer, Billerica, MA) and the degree of substitution of 
FA molecules was measured using an UV/Vis spectrometer (SpectraMax; Molecular 
Devices, Sunnyvale, CA). 
 Gelatin−based hypoxia−inducible (Gtn−HI) hydrogels were synthesized by 
carbodiimide-mediated coupling reaction as we previously reported[139]. Prior to 
polymer synthesis, we prepared a solvent by mixing DMSO and distilled (DI) water with 
1 to 1 volume ratio. We dissolved gelatin (1.0 g) in 50 ml of the solvent at 40 °C. FA 
(0.78 g, 4.0 mmol) was dissolved in 20 ml of the solvent and activated with EDC (0.92 g, 
4.8 mmol, 1.2 eq. of carboxyl unit of FA) and NHS (0.64 g, 5.6 mmol, 1.4 eq. of carboxyl 
unit of FA) at room temperature for 15 minutes to give amine reactive FA molecules. The 
activated solution was then applied to the Gtn solution and the conjugative chemical 
reaction was conducted at 40 °C. After 24 hours, the reacted solution was dialyzed 
against DI water using a dialysis membrane (molecular cutoff = 3500 Da) for five days. 
After dialysis, we obtained GtnFA polymers by freeze−drying and kept the product in a 
refrigerator (below 4 °C) before use. As previously [139], the chemical structure was 
confirmed using a 1H NMR spectrometer (Bruker AMX−300 NMR spectrometer, 
Billerica, MA) and the degree of substitution of FA molecules was measured using an 




2.1.2 Cancer cell Encapsulation within Geltain-Hypoxic Inducible Hydrogels 
For cancer cell encapsulation, all solutions were prepared using Dulbecco's 
Phosphate−Buffered Saline (DPBS, Invitrogen) and filtered for sterilization using a 
syringe filter with a pore size of 0.2 μm. First, we prepared cell pellets of and KIA or 
KIA-GFP or KIA- HIF–1α - or KIA-Scr (1.0 × 106 cells; derived from a genetic murine 
model of sarcoma, LSL-KrasG12D/+; Ink4a/Arf fl/fl as established previously [140] in 1.5 ml 
eppendorf tubes. We then mixed the pellets with 375 μl of polymer stock solution (4% 
Gtn−FA solution) by gentle pipetting to give homogeneous cell suspensions and added 
125 μl of laccase stock solution (100 U/ml). After mixing the enzyme, the solution was 
incubated at 37 °C for 2 minutes and then transferred to a 96−well plate (BD Bioscience). 
The cells were cultured within the hydrogel matrices under standard culture conditions 
(37 °C and 5% CO2) in high−glucose DMEM with 10% fetal bovine serum (FBS), 1% 
Penicillin−Streptomycin (PS, Invitrogen) and 1% L−glutamine (Invitrogen). The final 
concentration of cells, polymers, and laccase were 1.0−2.0 × 106 cells/ml, 3%, and 25 
U/ml, respectively. The cancer cell morphology was observed by light microscopy (in 
phase−contrast mode) and fluorescence microscopy (BX60, Olympus, Tokyo, Japan). 
2.2 Collagen Gels 
2.2.1 Collagen Gel Formation  
The collagen gel synthesis protocol was adapted from previously established 
protocols [118, 141, 142]. In order to make 1 mL of 3 mg/mL collagen solution, we first 
mixed 35.96 μL of M199 10x media (Thermo Fisher Scientific) with 11.51 μL of 1M 
NaOH. This solution was mixed until it turned dark pink. Next we used acid soluble rat 




added to the dark pink solution and mixed thoroughly. 640.35 mL of M199 1x media 
(Thermo Fisher Scientific) was then mixed with the solution to create our final collagen 
gel solution. The solution was then incubated for 30 minutes on ice to create a low fiber 
density solution and 2 hours on ice to create a high fiber density solution.  
2.2.2 Cacner Cell Encapsulation in Collagen Gels 
KIA was derived from a genetic murine model of sarcoma, LSL-KrasG12D/+; 
Ink4a/Arffl/fl as established previously [40], KIA-GFP was expanded under standard 
culture conditions (37°C and 5% CO2) in high glucose DMEM with 10% FBS, 1% 
penicillin/streptomycin (PS; Invitrogen). For cancer cell encapsulation, we first prepared 
cell pellets of KIA and KIA-GFP cells (7.5 x 105 cells) in a 1.5 mL eppendorf tube. We 
then mixed the pellet with 0.5 mL of collagen solution by gentle pipetting to give a 
homogenous cell suspension. After mixing, the solution is pipetted into a 96 well plate 
(BD Bioscience) and incubated for 30 minutes at 37°C. The nonhypoxic gels were 
created with 50 μL of collagen while the hypoxic gels were made from 100 μL of 
collagen solution. The cells were then cultured within the hydrogel matrices under 
standard culture conditions in DMEM (Dow Corning) with 10% heat-inactivated fetal 
bovine serum (Gibco) and 1% penicillin streptomycin. 200 μL of media was used to 
culture the hypoxic gels and 100 μL was used to culture the nonhypoxic gels.  
2.3 Rheology 
To analyze matrix stiffness, we performed rheological analysis of the hydrogels 
using a rheometric fluid spectrometer (RFS3, TA Instruments, New Castle, DE) as we 
previously reported[139]. In the rheological experiments, tumor constructs cultured 




the samples after day 3 in culture. We monitored the elastic modulus (G’) and viscous 
modulus (G”) at 1 percent of strain and a frequency of 10 Hz at 37 °C. A solvent trap 
wetted with deionized water was used to prevent sample evaporation. 
Stress relaxation experiments were performed on RSAG2 dynamic mechanical 
analyzer from TA instruments. The initial elastic moduli and stress relaxation properties 
of collagen gels were measured from compression tests of the gel disks (6 mm in 
diameter, 2 mm thick, equilibrated in PBS for 24 h. The gel disks were compressed to 
10% strain. Stress relaxation under shear mode was performed on  an AR1500 EX 
rheometer from TA instruments.  Collagen gel  disks of 6 mm in size were used to 
perform the stress relaxation tests at 0.5% strain for 5 minutes.  As previously 
performed[71], single element Maxwell model was used to fit the stress relaxation data in 
order to compare the time decay constants for different conditions Invasive and Non-
Invasive Oxygen Measurements 
The dissolved oxygen (DO) levels were monitored noninvasively and invasively as 
previously performed[59].  We used a commercially available sensor patch (PreSens) for 
the non-invasive measurements and a Needle-Type Housing Fiber-Optic Oxygen 
Microsensor (PreSens) for invasive measurements. Hydrogel cell constructs were created 
as stated above, and DO measurements were performed on day 3 of cell culture.  
Tumors were generated as previously stated, and DO measurements were 
performed once tumors were visible. O2 gradient measurements were performed using the 
needle sensor and a micromanipulator (PreSens). The tumor diameter was measured 




in 0.5 mm increments, recording a DO reading at each distance, until reaching the edge of 
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where V is the volume of the tumor, L is the major axis, and W is the minor axis of 
the tumor [143]. The tumor O2 measurements were averaged and the standard error mean 
was calculated for each distance from the center of the tumor. 
This same technique was used to evaluate the O2 gradient in the hydrogel at day 
1,3,5 and 7 in the KIA encapsulated samples. It should be noted that in vitro invasive 
measurements might deviate a little from non-invasive measurements as the insertion of 
the needle can result in uncontrolled O2 penetration into the hydrogel.  
2.4 Matrix Degradation and Migration Analysis  
To assess effect of O2 levels on matrix degradation, we incorporated 10 μg/ml of 
DQTM gelatin or collagen (Invitrogen) into polymer solutions when preparing cell 
suspensions, and then mixed with the laccase solution as described above. After day 3, 
the hydrogels with DQ−gelatin  or collagen was observed by the fluorescence microscopy 
(BX60, Olympus, Tokyo, Japan) and quantified by measuring the fluorescence intensity 
using a fluorescence spectrophotometer at wavelength of 495 nm excitation and 515 nm 
emission (Molecular Devices). 
For the 3D cancer cell migration assay, we encapsulated KIA-GFP cells and 
tumor grafts in hydrogel to generate constructs with different O2 levels as previously 
[139]. For non-gradient hydrogel controls, constructs were formed and incubated at 1% 
oxygen for 3 days and then tracked in that chamber at day 3. Cells were tracked at day 3 




Thornwood, NY, USA) equipped with a cell incubator (5% CO2 and 37 °C). In order to 
properly optimize the experiment only cells that started in frame were included, with a 
shorter timeframe was used for the tumor encapsulated samples. The time-lapse and 
z−stack images (>200 μm thickness) were collected every 30 minutes up to 24 hours at 
five randomly selected positions. The images were analyzed using Imaris spot analysis 
(Imaris 8.1, Bitplane, South Windsor, CT, USA) software to track the time−dependent 
mobility. The 3D migration analysis was performed following the strategy developed by 
Wirtz and colleagues [144, 145].  A minimum of 100 individual cells at each point were 
tracked to generate x, y, and z coordinates at each time point. This data was then sorted to 
only include cells that were present at time zero. From this sorted data the time that the 
cells were in frame was calculated, and the most common time was used to pick cells for 
tracking analysis. This was done to maximize the sample size of cells that could be 
analyzed. Finally, velocity and speed profiles, mean squared displacements, and 
trajectory plots were calculated using code adapted from Wirtz et al [144, 145] for 
triplicate tracking trials (n=3) (Matlab, Mathworks Inc.). The statistical analysis was 
performed using MATLAB (Mathworks Inc.) to calculate the mean, standard deviation 
and standard error mean. A t-test was performed where appropriate to determine 
significance (GraphPad Prism 4.02). Graphed data is presented as average ±SD. 
Significance levels were set at: *P<0.05; ^P<0.01; #P<0.001[144, 145]. 
2.5 Molecular Biology 
2.5.1 Gene Expression 
To assess gene expression, we performed quantitative real time RT−PCR as 




hydrogels using TRIzol (Invitrogen), according to the manufacturer’s instructions. In 
brief, we placed the hydrogel constructs into 500 μl of TRIzol and homogenized using a 
micro homogenizer. The suspension was centrifuged at 12,000 G for 15 minutes and the 
supernatant was separated. We then added 100 μl of chloroform to the solution and mixed 
manually for 20 seconds. The mixture was centrifuged at 12,000 G for 10 minutes and 
the supernatant was isolated. The solution was mixed with 250 μl isopropyl alcohol and 
kept at −4 °C for 1 hour. The precipitates were separated by centrifugation at 7,500 G for 
5 minutes and then washed using 70% ethyl alcohol (EtOH). Total RNA was quantified 
using an ultraviolet (UV) spectrometer and validated by lack of DNA contamination. One 
microgram of RNA was transcribed using reverse transcriptase M−MLV and oligo(dT) 
primers (both from Promega, Madison, WI), according to the manufacturer’s instructions. 
We used TaqMan Universal PCR MasterMix and Gene Expression Assay (Applied 
Biosystems, Foster City, CA), according to the manufacturer’s instructions for LOX, 
MMP2, MMP9, PLOD2, col1A, HPRT1, and β−actin.  
2.5.2 Histology 
For histological analysis, hydrogel constructs or tumors were harvested and fixed 
using 3.7% paraformaldehyde and then dehydrated in graded EtOH (80−100%). We then 
embedded the samples in paraffin blocks and serially sectioned them using a microtome 
(5 μm). The slides were stained with either haematoxylin or eosin (H&E) or underwent 
immunohistochemistry for HIF–1α  as previously described [140]. For quantification of 
HIF–1α positive cells in tumor sections, cells expressing nuclear HIF–1α  were counted 
manually from 40x images (n=8). The total number of cells in the images were counted 




performed on the data to determine significance (GraphPad Prism 4.02). Graphed data is 
presented as average ±SD. Significance levels were set at: P<0.05; **P<0.01; 
***P<0.001. 
2.5.3 Immunoflorescence Analysis 
Hydrogels were fixed using 3.7% paraformaldehyde and incubated at room 
temperature for 1 hour. For staining the cells were permabolized with 0.05% Triton-X for 
30 minutes, washed with PBS and incubated with primary antibodies over night. The 
primary antibody used with collagen 1, HIF–1α  (Novous Biologicals, Littleton, CO), 
YAP (Santa-Cruz), and Vinculin (Sigma-Aldrich) . Certain samples were rinsed with 
PBS and incubated with Alexa Fluor 546 (1:500; Invitrogen) for 1 hour, followed by 
incubation with Alexa Fluor 488 Phalloidin (1:40; Invitrogen) for 30 minutes and with 4-
6-diamidino-2- phenylindole, DAPI, (1:1000; Roche Diagnostics) for 10 minutes. The 
labeled cells were examined using fluorescence microscopy (LSM 780, Carl Zeiss, 
Thornwood, NY, USA). Collagen fluorescence intensity was analyzed using ImageJ 
(ImageJ, National Institutes of Health, Bethesda, MD).  
2.5.4 Statistical Analysis 
All experiments were performed in triplicate for at least 3 biological replicates. 
We performed RT-PCR analysis in triplicate with duplicate readings. We performed 
statistical analysis using GraphPad Prism 4.02 (GraphPad Software Inc., La Jolla, CA).  
For all analyses other than the live migration (which its statistics is detailed above), the 
standard deviation and t-test were performed on the data to determine significance 
(GraphPad Prism 4.02). Graphed data is presented as average ±SD. Significance levels 




3 Intra-tumoral Oxygen Gradients Lead to 
Sarcoma Cell Migration 
 
3.1 Introduction 
Soft tissue sarcomas are a heterogeneous group of malignant cancers derived from 
transformed cells of mesenchymal origin [146, 147]. Approximately 13,000 new cases 
per year are diagnosed in the US alone, with 25–50% of patients developing recurrent 
and metastatic disease [148-150]. Current clinical data suggest that undifferentiated 
pleomorphic sarcoma (UPS) is one of the most aggressive sarcoma subtypes, which 
frequently results in lethal pulmonary metastases that are insensitive to 
radio/chemotherapy. It has recently become apparent that sarcoma progression and 
metastasis are regulated by microenvironmental cues such as extracellular matrix (ECM) 
remodeling, stiffness modulation, cell-to-cell/matrix interactions, signaling factors, and 
spatial gradients [151-153]. Of all these factors, low intratumoral O2 (hypoxia) is most 
dramatically associated with pulmonary metastasis, and poor clinical outcomes [154, 
155]. 
Intratumoral hypoxia occurs when the partial pressure of O2 falls below 5% and is a 
commonly observed feature of many sarcomas. Regional hypoxia develops as rapidly 
growing tumors outstrip their blood supply and as a consequence of aberrant tumor 




hypoxia promotes chemo- and radiation resistance, primarily due to limited perfusion and 
reduced generation of reactive oxygen species (ROS), respectively[156]. Moreover, the 
stabilization and activation of Hypoxia Inducible Factor (HIF) transcriptional regulators 
promotes adaptation to hypoxic stress by modulating tumor cell metabolism, survival, 
angiogenesis, migration, invasion, and metastasis. Elevated HIF expression has been 
associated with poor prognosis in many cancers[157] and correlates with reduced 
survival for sarcoma patients. Recent transcriptome analyses have identified HIFs and 
HIF target genes as independent prognostic indicators[158] of clinical outcomes. Finally, 
high levels of intratumoral hypoxia and HIF1- accumulation are among the most 
important predictors of metastatic potential in patients with sarcoma[159], although the 
underlying mechanisms for this correlation remain incompletely characterized. 
Importantly, while the effect of overall reduced O2 on sarcoma cell responses has been 
studied; these cells are actually subjected to O2 gradients. Currently, the impact of 
specific oxygen gradients on sarcoma cell migration is unclear. 
In previous studies we found that deposition of immature collagen networks 
facilitated tumor cell metastasis to the lung in a HIF–1α dependent manner [140]. We 
also demonstrated that the HIF–1α regulated sarcoma metastasis through upregulation of 
procollagen–lysine, 2–oxoglutarate 5–dioxygenase (PLOD2) and the resulting increase in 
lysine hydroxylation of collagen molecules [140]. We have shown that PLOD2 
expression promotes metastasis in a hypoxia-  HIF–1α 
genetic in vivo model of UPS [140]. However, we do not yet know how sarcoma cell 




Using in situ O2  measurements, we found that hypoxia gradients exist in small 
primary mouse sarcoma tumors while large primary mouse sarcoma tumors contain 
severe hypoxic cores (≤0.1% pO2). To model intratumoral O2-gradients we used novel 
O2-controlling hydrogels that can serve as 3D hypoxic microenvironments [139]. In these 
hypoxia-inducible (HI) hydrogels, O2 is consumed while polymerization occurs resulting 
in spatial O2 gradients. Thus, with these hydrogels we can mimic physio-pathological O2 
gradients. By encapsulating small tumor grafts in the hydrogels, we found that hypoxic 
gradients promoted cell invasion with faster speeds and longer distance, compared to 
nonhypoxic gradients. We next demonstrate that the HI hydrogel culture system 
replicates HIF–1α-dependent collagen remodeling by sarcoma cells. Using this system, 
we then show that the hypoxic gradients guide the speed, distance, and direction of 
sarcoma cell motility compared with nonhypoxic hydrogels. Finally, we show that 
treatment of the encapsulated sarcoma cells with minoxidil abrogates cell migration and 
matrix remodeling in the O2 gradient. 
3.2 Materials and Methods 
3.2.1 Materials 
 Gelatin (Gtn, type A from porcine skin, less than 300 bloom), laccase (lyophilized 
powder from mushroom, ≥4.0 units/mg), 3−methoxy−4−hydroxycinnamic acid (ferulic 
acid, FA), N−(3−dimethylaminopropyl)−N´−ethylcarbodiimide hydrochloride (EDC), 
N−hydroxysuccinimide (NHS), dimethyl sulfoxide (DMSO), and deuterium oxide (D2O) 
were supplied from Sigma−Aldrich (Saint Louis, MO) and used as obtained without 
purification. Dialysis membrane (molecular cutoff = 3500 Da) was purchased from 




3.2.2 Synthesis of Gtn-HI hydrogels 
 Gelatin based hypoxia−inducible (Gtn−HI) hydrogels were synthesized by 
carbodiimide-mediated coupling reaction as we previously reported[139]. Prior to 
polymer synthesis, we prepared a solvent by mixing DMSO and distilled (DI) water with 
1 to 1 volume ratio. We dissolved gelatin (1.0 g) in 50 ml of the solvent at 40 °C. FA 
(0.78 g, 4.0 mmol) was dissolved in 20 ml of the solvent and activated with EDC (0.92 g, 
4.8 mmol, 1.2 eq. of carboxyl unit of FA) and NHS (0.64 g, 5.6 mmol, 1.4 eq. of carboxyl 
unit of FA) at room temperature for 15 minutes to give amine reactive FA molecules. The 
activated solution was then applied to the Gtn solution and the conjugative chemical 
reaction was conducted at 40 °C. After 24 hours, the reacted solution was dialyzed 
against DI water using a dialysis membrane (molecular cutoff = 3500 Da) for five days. 
After dialysis, we obtained GtnFA polymers by freeze−drying and kept the product in a 
refrigerator (below 4 °C) before use. As previously [139], the chemical structure was 
confirmed using a 1H NMR spectrometer (Bruker AMX−300 NMR spectrometer, 
Billerica, MA) and the degree of substitution of FA molecules was measured using an 
UV/Vis spectrometer (SpectraMax; Molecular Devices, Sunnyvale, CA). 
3.2.3 Cancer cell culture within Gtn-HI Hydrogels 
For cancer cell encapsulation, all solutions were prepared using Dulbecco's 
Phosphate−Buffered Saline (DPBS, Invitrogen) and filtered for sterilization using a 
syringe filter with a pore size of 0.2 μm. First, we prepared cell pellets of and KIA or 
KIA-GFP or KIA- HIF–1α - or KIA-Scr (1.0 × 106 cells; derived from a genetic murine 
model of sarcoma, LSL-KrasG12D/+; Ink4a/Arf fl/fl as established previously [140] in 1.5 ml 




Gtn−FA solution) by gentle pipetting to give homogeneous cell suspensions and added 
125 μl of laccase stock solution (100 U/ml). After mixing the enzyme, the solution was 
incubated at 37 °C for 2 minutes and then transferred to a 96−well plate (BD Bioscience). 
The cells were cultured within the hydrogel matrices under standard culture conditions 
(37 °C and 5% CO2) in high−glucose DMEM with 10% fetal bovine serum (FBS), 1% 
Penicillin−Streptomycin (PS, Invitrogen) and 1% L−glutamine (Invitrogen). The final 
concentration of cells, polymers, and laccase were 1.0−2.0 × 106 cells/ml, 3%, and 25 
U/ml, respectively. The cancer cell morphology was observed by light microscopy (in 
phase−contrast mode) and fluorescence microscopy (BX60, Olympus, Tokyo, Japan). 
3.2.4  Primary Tumor Formation, DO Measurements and Encapsulation 
For primary tumor encapsulation, we generated mouse sarcomas through 
subcutaneous injection of 1.0 × 106 cells/ml of KIA into nude mice. After day 10 we 
isolated tumors and prepared tumor discs (diameter, 3.0 mm; thickness, 0.4 mm) by 
biopsy punching. The tumor specimens were encapsulated within the different thickness 
hydrogels (hypoxic, 2.5 mm thickness; nonhypoxic, 1.25 mm thickness). For tumor 
encapsulation, we first prepared 5 μl of the hydrogel pad (3 w/v% Gtn−HI) on a 96 well 
plate, and then placed the tumor specimens on the pad. The mixture of polymer 
and laccase solutions was applied to the wells, and entire hydrogel construct was cultured 
under standard cell culture conditions (37 °C and 5% CO2) in either regular media (high 
glucose DMEM with 10% FBS, 1% PS, and 1% L−glutamine) for up to two weeks. The 
O2 levels during the culture period were monitored using noninvasive O2 sensors as 
described above. For quantification of 3D tumor invasion, we took 3−5 images of 




thickness) and measured the distance from the edge of tumor to the end of the tumor 
invading the hydrogel matrices using ImageJ software. To monitor real−time tumor 
invasion and migration, we encapsulated tumors generated from KIA-GFP cells. 
3.2.5 Non-invasive O2 measurement during cell and tumor graft culture 
The DO levels were monitored non−invasively at the bottom of hydrogels using 
commercially available sensor patches (Presens, Regensburg, Germany), as previously 
established [139, 160].  For DO measurement, the cell suspension (75 μl of polymer and 
cell suspension) and laccase solution (25 μl of 100 U/ml laccase stock solution) were 
mixed and incubated for 2 min, and then plated on the O2 sensor attached to a 96−well 
plate (BD Bioscience). All measurements were performed under standard cell culture 
conditions (37 °C and 5% CO2) in the culture media. To vary O2 tension, we controlled 
the thickness of hydrogels in a volume−dependent manner. We generated three kinds of 
hydrogels with different minimum dissolved O2 (DOmin) levels (defined as hypoxic gels,  
<1% O2; hypoxic−nonhypoxic gel, 5−8% O2; nonhypoxic gel, >8% O2). For example, to 
generate hypoxic gels we plated 100 μl (2.5 mm thickness) of a mixture including 
polymer, cells, and laccase solutions into a well, whereas 50 μl (1.25 mm thickness) of 
the mixture was plated into the well for preparing nonhypoxic gels. 
3.2.6 Invasive O2 gradient measurements 
The O2 levels in vivo were measured using Needle-Type Housing Fiber-Optic O2 
Microsensor (PreSens, Regensburg, Germany). These needle sensors were mounted on a 
micromanipulator with 10 μm precision (PreSens). Hydrogel-cell constructs were 
generated as detailed above. Tumors were generated as previously stated, and DO 




performed using the needle sensor and a micromanipulator (PreSens). The tumor 
diameter was measured using a caliper and the needle was placed at the center of the 
tumor and moved outward in 0.5 mm increments, recording a DO reading at each 
distance, until reaching the edge of the tumor. The volume of the tumor was calculated 
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where V is the volume of the tumor, L is the major axis, and W is the minor axis of the 
tumor [143]. The tumor O2 measurements were averaged and the standard error mean 
was calculated for each distance from the center of the tumor. 
This same technique was used to evaluate the O2 gradient in the hydrogel at day 1,3,5 and 
7 in the KIA encapsulated samples. It should be noted that in vitro invasive 
measurements might deviate a little from non-invasive measurements as the insertion of 
the needle can result in uncontrolled O2 penetration into the hydrogel. 
3.2.7 Matrix degradation, migration assay, and drug treatment 
To assess effect of O2 levels on matrix degradation, we incorporated 10 μg/ml of DQ
TM 
gelatin (Invitrogen) into polymer solutions when preparing cell suspensions, and then 
mixed with the laccase solution as described above. After day 3, the hydrogels with 
DQ−gelatin was observed by the fluorescence microscopy (BX60, Olympus, Tokyo, 
Japan) and quantified by measuring the fluorescence intensity using a fluorescence 
spectrophotometer at wavelength of 495 nm excitation and 515 nm emission (Molecular 
Devices). 
For the 3D cancer cell migration assay, we encapsulated KIA-GFP cells and tumor grafts 




gradient hydrogel controls, constructs were formed and incubated at 1% oxygen for 3 
days and then tracked in that chamber at day 3. Cells were tracked at day 3 using live-cell 
three-dimensional confocal microscopy (LSM 780, Carl Zeiss, Thornwood, NY, USA) 
equipped with a cell incubator (5% CO2 and 37 °C). In order to properly optimize the 
experiment only cells that started in frame were included, with a shorter timeframe was 
used for the tumor encapsulated samples. The time-lapse and z−stack images (>200 μm 
thickness) were collected every 30 minutes up to 24 hours at five randomly selected 
positions. The images were analyzed using Imaris spot analysis (Imaris 8.1, Bitplane, 
South Windsor, CT, USA) software to track the time−dependent mobility. The 3D 
migration analysis was performed following the strategy developed by Wirtz and 
colleagues [144, 145].  A minimum of 100 individual cells at each point were tracked to 
generate x, y, and z coordinates at each time point. This data was then sorted to only 
include cells that were present at time zero. From this sorted data the time that the cells 
were in frame was calculated, and the most common time was used to pick cells for 
tracking analysis. This was done to maximize the sample size of cells that could be 
analyzed. Finally, velocity and speed profiles, mean squared displacements, and 
trajectory plots were calculated using code adapted from Wirtz et al [144, 145] for 
triplicate tracking trials (n=3) (Matlab, Mathworks Inc.). The statistical analysis was 
performed using MATLAB (Mathworks Inc.) to calculate the mean, standard deviation 
and standard error mean. A t-test was performed where appropriate to determine 
significance (GraphPad Prism 4.02). Graphed data is presented as average ±SD. 




For minoxidil treatment, the cells were cultured in hypoxic hydrogels as stated 
above for three days. On the third day, 0.5 mM minoxidil (dissolved in KIA cell culture 
media) was added to the wells and the cells were tracked for 24 hours. Untreated cultures 
served as controls. Cell tracking and data analysis was performed as above.  
3.2.8 PLOD2 Western Blot 
Low-oxygen conditions were maintained in a Ruskinn in vivO2 400 hypoxia work 
station. Simultaneously, KIA Cells were treated with vehicle or 0.5 mM Minoxidil 
diluted in DMEM culture media  (Sigma Aldrich) for 16 hours. Whole cell lysates were 
prepared in SDS/Tris pH 7.6 lysis buffer. Proteins were electrophoresed and separated by 
SDS-PAGE and transferred to nitrocellulose membranes and probed with the following 
antibodies: rabbit anti-GAPDH (Cell Signaling Inc.), and rabbit anti-PLOD2 
(Proteintech). 
3.2.9 Rheological analysis 
 To analyze matrix stiffness, we performed rheological analysis of the HI 
hydrogels using a rheometric fluid spectrometer (RFS3, TA Instruments, New Castle, 
DE) as we previously reported[139]. In the rheological experiments, tumor constructs 
cultured within HI hydrogels were plated in the instrument. We performed dynamic time 
sweep on the samples after day 3 in culture. We monitored the elastic modulus (G’) and 
viscous modulus (G”) at 10 percent of strain and a frequency of 0.1 Hz at 37 °C. A 






3.2.10 Gene Expression 
To assess gene expression, we performed quantitative real time RT−PCR as 
described previously. Total RNA was extracted from cancer cells encapsulated in 
hydrogels using TRIzol (Invitrogen), according to the manufacturer’s instructions. In 
brief, we placed the hydrogel constructs into 500 μl of TRIzol and homogenized using a 
micro homogenizer. The suspension was centrifuged at 12,000 G for 15 minutes and the 
supernatant was separated. We then added 100 μl of chloroform to the solution and mixed 
manually for 20 seconds. The mixture was centrifuged at 12,000 G for 10 minutes and 
the supernatant was isolated. The solution was mixed with 250 μl isopropyl alcohol and 
kept at −4 °C for 1 hour. The precipitates were separated by centrifugation at 7,500 G for 
5 minutes and then washed using 70% ethyl alcohol (EtOH). Total RNA was quantified 
using an ultraviolet (UV) spectrometer and validated by lack of DNA contamination. One 
microgram of RNA was transcribed using reverse transcriptase M−MLV and oligo(dT) 
primers (both from Promega, Madison, WI), according to the manufacturer’s instructions. 
We used TaqMan Universal PCR MasterMix and Gene Expression Assay (Applied 
Biosystems, Foster City, CA), according to the manufacturer’s instructions for LOX, 
PLOD2, col1A1, and β−actin. 
3.2.11 Histological Analysis 
 For histological analysis, hydrogel constructs or tumors were harvested and fixed 
using 3.7% paraformaldehyde and then dehydrated in graded EtOH (80−100%). We then 
embedded the samples in paraffin blocks and serially sectioned them using a microtome 




immunohistochemistry for HIF–1α  as previously described [140]. For quantification of 
HIF–1α positive cells in tumor sections, cells expressing nuclear HIF–1α  were counted 
manually from 40x images (n=8). The total number of cells in the images were counted 
and percent positive cells were calculated. The standard deviation and t-test were 
performed on the data to determine significance (GraphPad Prism 4.02). Graphed data is 
presented as average ±SD. Significance levels were set at: P<0.05; **P<0.01; 
***P<0.001.  
3.2.12 Immunoflorescence analysis 
Hydrogels were fixed using 3.7% paraformaldehyde and incubated at room 
temperature for 1 hour. For staining the cells were permabolized with 0.05% Triton-X for 
30 minutes, washed with PBS and incubated with primary antibodies over night. The 
primary antibody used with collagen 1 or HIF–1α  (Novous Biologicals, Littleton, CO). 
Certain samples were rinsed with PBS and incubated with Alexa Fluor 546 (1:500; 
Invitrogen) for 1 hour, followed by incubation with Alexa Fluor 488 Phalloidin (1:40; 
Invitrogen) for 30 minutes and with 4-6-diamidino-2- phenylindole, DAPI, (1:1000; 
Roche Diagnostics) for 10 minutes. The labeled cells were examined using fluorescence 
microscopy (LSM 780, Carl Zeiss, Thornwood, NY, USA). Collagen fluorescence 
intensity was analyzed using ImageJ (ImageJ, National Institutes of Health, Bethesda, 
MD). 
3.2.13 Statistical analysis 
 All experiments were performed in triplicate for at least 3 biological replicates. 




statistical analysis using GraphPad Prism 4.02 (GraphPad Software Inc., La Jolla, CA).  
For all analyses other than the live migration (which its statistics is detailed above), the 
standard deviation and t-test were performed on the data to determine significance 
(GraphPad Prism 4.02). Graphed data is presented as average ±SD. Significance levels 
were set at: P<0.05; **P<0.01; ***P<0.001. All graphical data were reported. 
3.3 Results and Discussion 
3.3.1 Primary sarcoma grafts invade hypoxic hydrogels 
To ascertain the physiological range of O2 gradients in the developing sarcoma 
tumor, we began by measuring dissolved O2 (DO) levels during the growth of primary 
mouse sarcoma tumors. The primary sarcoma tumors were generated in nude mice using 
murine sarcoma cells derived from KrasG12D/+; Ink4a/Arffl/fl tumors (KIA[161]) as 
described in previous studies [140]. O2 gradient measurements during growth of 
subcutaneous primary sarcomas showed that in large tumors (>300mm3) about 50% of 
the tumor mass is hypoxic (≤0.1% pO2). Smaller tumors exhibit hypoxic gradients 
throughout the tumor mass ranging from 0.1% pO2 at the center, to >6% pO2 in the outer 
layer bordering the edge of the tumor (Figure 3-1A). Histological analysis further 
revealed the severe hypoxic tumor core with cells expressing HIF–1α localized to the 
nuclei in the larger tumor, while weaker and more diffused HIF–1α signal was observed 
throughout the entire smaller tumors (Figure 3-1B-C; Supplementary Figure 3-1). 
Previously, we have established O2-controlling hydrogels and found that after hydrogel 
formation, the DO levels at the bottom of hydrogels decreased as gel thickness increased 
due to oxygen diffusion limitation, resulting in a broad range of O2 tensions within the 




sought to use the O2-controllable hydrogel system to provide a more physiologically 
relevant 3D microenvironment to study cell migration.  Using the hypoxic hydrogel 
system we recreated the hypoxic DO conditions found in the subcutaneous in vivo tumors 
and evaluated the role of O2 in 3D tumor cell migration assay. Tumor biopsy punches 
from smaller tumors were cut into 8mm sections and grafted into the hypoxic and 
nonhypoxic hydrogels (Figure 3-1D). Using noninvasive DO measurements at the 
bottom of the hydrogels, we found that DO levels in the hypoxic hydrogels reached <5% 
pO2 within initial 30 min and remained there during the entire week of measurements. 
Nonhypoxic hydrogels exhibited a higher level of O2 (>5% partial pressure of O2) during 
this culture period (Figure 3-1E). The tumor engrafted within hypoxic matrix 
demonstrated increased invasion compared with tumors engrafted within nonhypoxic 
matrix. Specifically, tumors in hypoxic matrix invaded further into the hydrogel and 
away from the primary graft (after 1 week, 610 ± 210 µm) compared to those 
encapsulated in nonhypoxic gels (after 1 week, 410 ± 130 µm) (Figure 3-1F). Moreover, 
migrating cells exiting tumor grafts in the hypoxic hydrogel deposited new collagen 






Figure 3-1: Enhanced invasion of sarcoma tumor grafts in hypoxic hydrogels.  
(A) In situ DO measurements in KIA tumors. (B) H&E stains and (C) HIF1–α stains 
(left) and quantification (right) of small and large tumors. Scale bars, 200 µm for 




encapsulation within HI hydrogel matrix. (E) DO levels of HI hydrogels 
encapsulated with tumor biopsy in hypoxic and nonhypoxic matrixes up to day 7 in 
culture (F) Left: Light microscope (left) and fluorescence microscope (right) images 
of sarcoma tumors encapsulated within nonhypoxic and hypoxic matrices 
(phalloidin in green; nuclei in blue). H, hydrogels; T, tumors. Scale bars, 100 µm. 
Right: Quantitative analysis of the sarcoma tumor invasion into hydrogel matrix, 
(G) Immunofluorescence staining and quantification of collagen deposition by 
tumor grafts cultured for 7 days (collagen in red; nuclei in blue). Scale bars, 25 µm. 
Significance levels were set at *P<0.05, **P<0.01 and ***P<0.001. 
3.3.2 Cell migration from sarcoma grafts is regulated by O2 gradients 
To further investigate the effect of O2 gradients on sarcoma tumor migration, we 
performed real-time confocal analysis. Tumors generated from green fluorescent protein 
(GFP) positive KIA cells were engrafted in hypoxic and nonhypoxic hydrogels and 
imaged on day 3 when we first detected cell invasion into the hydrogel (Figure 3-2A). 
We then analyzed cell migration on day 3, when we could first detect cell invasion from 
the tumor to the hydrogel.  We observed dynamic cell movement in the hypoxic 
constructs compared to the nonhypoxic constructs with more cells migrating out of the 
grafts under hypoxic conditions  (Figure 3-2B and Supplementary Figure 3-2). Cell 
velocity analysis did not indicate specific directionality of migration with most cells 
moving in the x and y planes, suggesting a random migration path independent of O2 
tension (Supplementary Figure 3-3). However, we found a higher migration speed in 
hypoxic grafts compared to nonhypoxic grafts (Figure 3-2C). Examining mean square 
displacement (MSD) in the three planes, we found that cells migrating in the hypoxic 
gradients move to larger distances compared to the nonhypoxic gradients with 
significantly longer distance in the z-direction (Figure 3-2D) suggesting that while cells 




exhibited higher persistence. Overall, these data show that hypoxic gradient promotes 
tumor cell migration. 
 
Figure 3-2: Hypoxia promote primary sarcoma migration  
(A) Light microscope (left) and fluorescence microscope (right) images of day 3 
images of KIA-GFP sarcoma tumors encapsulated within nonhypoxic and hypoxic 
matrices. Migrating GFP cells were tracked to determine (B) Three-dimensional 
trajectories of tracked cells (representative trajectories) (C) Overall speed, and (D) 
Mean square displacement (MSD) in the x, y, and z directions. Plots were created 
using position of KIA-GFP cells in the hydrogels. Significance levels were set at 




3.3.3 Sarcoma cells remodel collagen in hypoxic hydrogels 
While the tumor graft model provides vital information, the inherited 
heterogeneity of the system limited the mechanistic insights that such system can 
provide. To more accurately model the effect of DO gradients on sarcoma cell invasion/ 
migration within a complex tumor microenvironment, we next examined individual 
sarcoma cells embedded in the HI hydrogel [139]. Non-invasive measurements of DO at 
the bottom of the hydrogel confirmed that the hypoxic matrix maintains low O2 levels 
during the 7 days of culture compared to nonhypoxic matrix (Figure 3-3A). Notable, by 
day 7 in culture oxygen levels have decreased to ~0.5%, likely to due to expansion of the 
cell number over the longer culture period and the associated cellular oxygen 
consumption [162]. An important feature of this culture system is the ability to maintain 
the hypoxic gradient environment without exposure to high oxygen levels thus 
minimizing the introduction of reactive oxygen species (ROS). This, alongside with the 
ability to perform live-imaging of the cells while monitoring DO levels present a unique 
opportunity to link cellular responses to DO gradients. Growing evidence suggests that 
ECM remodeling is critical in sarcoma migration and metastasis. In particular, proteolytic 
degradation as well as abnormal collagen deposition and modification within hypoxic 
tumor microenvironments have been implicated as important parameters that enhance 
tumor invasion and metastasis [163-165]. The gelatin-based HI hydrogels provide matrix 
adhesion and degradation sites similar to those in the tumor microenvironment, yet are 
collagen-free to prevent confounding results. We first tested whether sarcoma cells 
embedded in hypoxic hydrogel remodel the matrix material. We examined the proteolytic 




when degraded by a protease secreted by the cells.[166, 167] Interestingly, we observed 
higher fluorescence intensity in the cells cultured within the hypoxic microenvironments 
(480 RFU) compared to nonhypoxic matrix (50 RFU) (Figure 3-3B). Rheological 
analysis further confirmed the softening of the hypoxic matrix (young’s modulus of 20 
Pa) compared to nonhypoxic matrix (young’s modulus of 45 Pa) within 3 days of culture 
(Figure 3-3C). The gelatin-based HI hydrogels further enabled us to examine whether 
sarcoma cells modify collagen in the hypoxic matrix. We next examined the upstream 
effect of HIF–1α activation on relevant genes on days 3 and 7. While no change in gene 
expression was detected on day 3 of culture, we observed an upregulation of Col1A1, 
LOX, and PLOD2 expression after 7 days of culture in the hypoxic hydrogel compared to 
the nonhypoxic hydrogel (Figure 3-3D). Moreover, at this time point, we detected 
collagen expression and deposition (Figure 3-3E) as well as HIF–1α expression 
(Supplementary Figure 3-4) by the sarcoma cells in the hypoxic hydrogel. To determine 
whether ECM remodeling is regulated by the HIF–1α in the hypoxic matrix, we used 
short hairpin RNA (shRNA). We detected significant down regulation of collagen 
modifying genes, Col1A1, LOX, and PLOD2 when HIF–1α expression was inhibited 
(Figure 3-3F), resulting in less collagen deposition in hypoxic hydrogel encapsulated 
cells compared to controls (Figure 3-3G). Overall, these results demonstrate that the 3D 
hypoxic hydrogel, regulates sarcoma matrix remodeling through hypoxic induction of 
HIF–1α expression. These results are consistent with various sarcoma studies in vivo 
[140, 168, 169], suggesting that the HI hydrogels are an appropriate 3D model with the 





Figure 3-3 Sarcoma cells remodel the hypoxic hydrogel.  
(A) Non-invasive DO readings at the bottom of the hypoxic and nonhypoxic 
hydrogel-sarcoma cell constructs. (B) Sarcoma cells encapsulated within HI 
hydrogels incorporating DQTM gelatin for 3 days: (i) Representative fluorescence 
microscopy images. Scale bars, 25 µm and (i) Quantitative analysis of relative 
fluorescence intensity (RFU). (C) Young’s modulus (Pa) of the hypoxic and 
nonhypoxic hydrogels on day 0 and after 3 days of culture. (D) Real–time RT–PCR 
analysis of collagen modification genes. (E) Immunofluorescence staining and 
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blue). Scale bars, 50 µm. The effect of HIF1–α suppression in encapsulated sarcoma 
cells (KIA_scr, a control; KIA_HIF–1α(–), HIF knock down) after 7 days in culture 
was analyzed including: (F) collagen modification gene expression and (G) collagen 
deposition and quantification (collagen in red; nuclei in blue). Scale bars, 50 µm. 
Graphical results shown as the average value ± s.d. Significance levels were set at 
*P<0.05, **P<0.01 and ***P<0.001. 
3.3.4 O2 gradients modulate the speed, distance, and directional bias of sarcoma 
cell motility 
As we previously shown, the HI-hydrogel system is designed to create an O2 
upward gradient, wherein DO levels increase toward the interface between the construct 
and O2 saturated culture media [139]. Encapsulation of individual cell suspension would 
provide us the opportunity to document single-cell movement in relation to the O2 
gradient (Figure 3-4Ai). As these constructs are cultured in air-oxygenated media, 
hypoxic and nonhypoxic upward gradients are maintained in each of the gel type [139]. 
Invasive DO measurements validated hypoxic and non-hypoxic gradients in the hydrogel-
cell constructs (Figure 3-4Aii and Supplementary Figure 3-5). These results confirm 
that we are able to successfully mimic the gradients seen in the primary tumor in vivo. 
Thus, we next examined how sarcoma cell motility is regulated by the O2 gradients in the 
3D hypoxic and nonhypoxic gradients. We encapsulated KIA-GFP in the HI hydrogels 
and analyzed movement on day 3 using real-time 3D cell tracking. Upon examining the 
3D trajectory profiles of the KIA-GFP encapsulated cells, we observed greater overall 
cell movement in the hypoxic gradients compared to the nonhypoxic gels (Figure 3-4B 
and Supplementary Figure 3-6). We also found that cells in the hypoxic gradient gels 
are moving faster than those in the nonhypoxic gels. This holds true for the velocity 
profiles in the x, y, and z directions as well as the overall speed of the cells moving 




direction, which has not been reported before. Importantly, cell velocity in the z-direction 
was primarily upwards, in the direction of increased O2 tension  (Figure 3-4D). We 
further computed and analyzed the MSD in the three planes. (Figure 3-4E). Here too, O2 
gradient seem to affect cell motility as indicated by the MSD in the z-direction. Cells 
exposed to the hypoxic gradients cells are traveling over larger distances compared to 
those in the nonhypoxic gradients (Figure 3-4E). Interestingly, non-gradient hypoxic 
constructs (ie- hydrogel constructs cultured in hypoxic conditions) showed slower cell 
movement and a lower mean squared displacement compared with hypoxic gradient 
constructs (Supplementary Figure 3-7). Overall, this data shows that increased DO 





Figure 3-4: Efficient sarcoma cell migration in hypoxic gradients  
(A) (i)- Illustration of hypoxic and nonhypoxic O2 gradient in HI hydrogels. (ii)- 
Invasive DO readings showing gradients in the HI hydrogels on Day 1 and 3. KIA-
GFP cells were tracked on day 3 in hypoxic and nonhypoxic hydrogel to determine 
(B) Three-dimensional trajectories of tracked cells (representative trajectories), (C) 




displacement (MSD) in the x, y, and z directions. Plots were created using position 
of KIA-GFP cells in the hydrogels. Significance levels were set at *P<0.05, ^P<0.01 
and #P<0.001. 
3.3.5 Inhibiting 3D hypoxic gradient migration 
We previously demonstrated that  
HIF–1α dependent manner in an in vivo model of UPS [140]. To examine whether the 
oxygen-controllable hydrogel faithfully represents the intratumoral hypoxic environment, 
we examined the effect of minoxidil, a pharmacologic inhibitor of PLOD2 expression 
[170], on sarcoma cell migration. Minoxidil treatment (0.5 mmol/L) for 12 hours of 
sarcoma cells encapsulated in the hypoxic hydrogels, significantly reduced KIA cell 
movement (Figure 3-5A and Supplementary Figure 3-8) concomitant with reduced 
overall cell speed as well as velocity and MSD in the x.y.and z directions (Figure 3-5B-
D). Minoxidil treatment of sarcoma cells encapsulated in the nonhypoxic hydrogels did 
not significantly affect cell migration in the X and Y directions, with slight inhibition of 
migration in the z-direction (Supplementary Figure 3-9). Examining matrix remodeling, 
we found that minoxidil treatment reduced collagen deposition (Figure 3-5E) and 
inhibited the proteolytic degradation of the hypoxic matrices (Figure 3-5F).  As 
expected, we found that hypoxia-induced PLOD2 expression is inhibited with Minoxidil 
treatment (Figure 3-5G). Together, this data shows that hypoxia gradients determine the 
direction and speed of sarcoma cell migration in a HIF1/PLOD2 dependent manner. 
Importantly, these findings also highlight the utility of hydrogel encapsulation assays for 
the identification of novel therapeutic targets and inhibitors for the treatment of 






Figure 3-5: Minoxidil inhibit sarcoma cell migration and matrix remodeling in 
hypoxic hydrogel.  
KIA-GFP cells were tracked on day 3 in hypoxic treated and untreated hydrogel to 
determine (A) Three-dimensional trajectories of tracked cells (representative 
trajectories), (B) Overall speed  (C) Velocity in the x, y, and z directions; and (D) 




using position of KIA-GFP cells in the hydrogels. (E) Collagen deposition and 
quantification (collagen in red; nuclei in blue). Scale bars, 50 µm. (F) Proteolytic 
degradation of HI hydrogels incorporating DQTM gelatin for 3 days: (i) 
Representative fluorescence microscopy images. Scale bars, 20 µm and (ii) 
Quantitative analysis of relative fluorescence intensity (RFU).(G) Western blot 
analyses for PLOD2 in KIA cells cultured in hypoxic conditions with and without 
minoxidil treatment. Significance levels were set at *P<0.05, ^P<0.01 and #P<0.001. 
 
3.4 Conclusions 
Leveraging our novel O2 controlling hydrogel, we generated a 3D in vitro model 
that enables us to analyze cancer cell responses to O2 gradients and the effect of small 
molecule inhibitors. Using this approach, the current study presents a new concept in 
which O2 acts as a 3D physico-tactic agent during early stages of sarcoma tumor 
invasion. We found that an O2 gradient is present in early stages of sarcoma development 
and that during this stage, cells respond to the hypoxic gradient by aggressively invading 
the matrix, followed by fast and long-distance migration. Moreover, we demonstrated 
that in hypoxic gradients individual sarcoma cells not only migrate faster and over a 
longer distance while remodeling the matrix, they also migrate in the direction of 
increased O2 tension. Finally, we showed that treatment with minoxidil inhibits the 
migration and matrix remodeling in the hypoxic gradient. These findings are important 
for the understanding of the metastatic process and establishing the 3D in vitro model as 
a platform for testing therapeutic targets and interventions for the treatment of cancer.  





Supplementary Figure 3-1: Primary mouse sarcoma tumors.  
Whole tumor showed using tiled micrographs of H&E stains and (left) HIF1 stains 
(right) of small and large tumors. Scale bars, 1 mm  
 
Supplementary Figure 3-2: Primary sarcoma tumor migration velocity.  
KIA-GFP sarcoma tumors were encapsulated within nonhypoxic and hypoxic 
matrices.  Day 3 migrating GFP cells were tracked to determine velocity in the x,y, 





Supplementary Figure 3-3: Primary sarcoma migration trajectories.  
2D Trajectories of tracked cells in (A) hypoxic and (B) non-hypoxic hydrogels. 
 




Representative immunofluorescence staining of HIF1α expression by the 
encapsulated cells (HIF1α in red; nuclei in blue). Note the abundant nuclear 
staining and cytoplasmic staining as it relates to rapid protein turnover in the 
hypoxic hydrogels. Scale bars, 25 µm. 
 
Supplementary Figure 3-5: DO gradient measurements.  





Supplementary Figure 3-6: Sarcoma cell migration trajectories.  





Supplementary Figure 3-7: Sarcoma migration in non-gradient gels.   
KIA-GFP cells were tracked on day 3 in non-gradient gels and compared to the cell 
migration in gradient hypoxic and non-hypoxic gels. (A) Overall speed  (C) Velocity 
in the x, y, and z directions; and (D) Mean square displacement (MSD) in the x, y, 






Supplementary Figure 3-8: Minoxidil treatment effect on sarcoma cell migration 
trajectories.  
2D Trajectories of tracked cells in (A) untreaded hydrogels and (B) hydrogels 





Supplementary Figure 3-9: Minoxidil treatment effect on sarcoma cell migration in 
nonhypoxic hydrogel.  
KIA-GFP cells were tracked on day 3 in nonhypoxic treated and untreated hydrogel 
to determine (A) Three-dimensional trajectories of tracked cells (representative 
trajectories), (B) Overall speed  (C) Velocity in the x, y, and z directions; and (D) 
Mean square displacement (MSD) in the x, y, and z directions. Plots were created 







4 Collagen Fiber Architecture Regulates 
Hypoxic Sarcoma Cell Migration. 
 
4.1 Introduction 
The complex tumor microenvironment includes a variety of components including 
stromal cells, blood and lymphatic vessels, and the extracellular matrix (ECM). Each of 
these factors can generate non-uniform mechanical and physico-chemical gradients 
within a tumor. A prominent physico-chemical gradient in the tumor microenvironment is 
intratumoral hypoxia.   Intratumoral hypoxia occurs when the oxygen partial pressure in 
the tissue drops to below 5%[171]. Hypoxia can trigger the upregulation of collagen 
modifiers [40] as well as a variety of cellular interactions and the recruitment of blood 
vessels[172]. In soft tissue sarcomas, hypoxic gradients lead to an increased metastatic 
potential and greatly decrease patient survival rates [40, 59].  
Several properties of the ECM, such as elastic modulus and stress relaxation time, 
have been shown to regulate cellular responses[71] including cell motility[72], 
mesenchymal stem cell differentiation [66], and the cell’s ECM sensing capability [73]. 
These properties are drastically different in different organs [173]. In the tumor ECM, the 
increase in collagen fiber density has been shown to promote human fibro-sarcoma 
migration speeds via beta-1-integrin [174]. Recently Ogawa et al have shown an 




addition, collagen crosslinkers such as lysyl oxidase (LOX) and procollagen-lysine, 2-
oxoglutarate 5-dioxygenase (PLOD2) have been shown to lead to a higher metastatic 
potential of sarcomic tumors [40, 59].   
Traditional two-dimensional (2D) cell culture platforms in which cells are attached 
to the culture surface and exposed to atmospheric air have limited physiological 
relevance. The over simplification of these platforms has led to the development of three-
dimensional (3D) platforms that mimic the tumor microenvironment in vitro. Such 3D 
platforms can aid in the understanding of tumor cell and microenvironment interactions. 
However, in order  to study cell motility within a 3D ECM, there is a need to design 
biomaterials where such properties like crosslinking density[176], pore size[177, 178], 
and fiber density[142, 174] can be controlled. Furthermore, the combined effects of ECM 
properties and chemotactic gradients have added further complexity to the problem, with 
the underlying mechanism poorly understood.  For example, most current approaches 
either overlook the gradients generated in the tumor microenvironment or are unable to 
decouple matrix properties from chemotactic gradients. Hydrogel biomaterials, due to 
their unique viscoelastic characteristics[179], may offer opportunities to address some of 
these limitations and can uncover the important biological responses.  
In this study we aim to understand how hypoxic gradients affect sarcoma cell 
migration in a hydrogel-based, collagen-rich, fibrous ECM platform. In the collagen 
hydrogel platform, collagen fiber density is controlled by altering pre-incubation periods 
of collagen solution prior to polymerization. Oxygen gradients are modulated by 
controlling the passive diffusion of atmospheric (~21%) O2 (via modifying hydrogel 




demonstrated for the first time the synergistic effect of oxygen gradients and collagen-
rich matrix properties on sarcoma cell migration. Using a mouse undifferentiated 
pleomorphic sarcoma (KIA cells) line, we found that hydrogels with denser collagen 
fibers have a shorter stress relaxation time and larger pore sizes that lead to an increased 
speed of sarcoma cell motility. We further demonstrated the additive effect of hypoxic 
gradients on increasing sarcoma cell migration by comparing the mean squared 
displacements (MSD) of cells in hypoxic-gradient and nonhypoxic hydrogel matrices.  
4.2 Materials and Methods 
4.2.1 Collagen Gel Preparation 
The collagen gel synthesis protocol was adapted from previously established 
protocols [118, 141, 142]. In order to make 1 mL of 3 mg/mL collagen solution, we first 
mixed 35.96 μL of M199 10x media (Thermo Fisher Scientific) with 11.51 μL of 1M 
NaOH. This solution was mixed until it turned dark pink. Next we used acid soluble rat 
tail collagen I at 9.61 mg/mL (Corning #354249). A total of 312 μL of collagen was 
added to the dark pink solution and mixed thoroughly. 640.35 mL of M199 1x media 
(Thermo Fisher Scientific) was then mixed with the solution to create our final collagen 
gel solution. The solution was then incubated for 30 minutes on ice to create a low fiber 
density solution and 2 hours on ice to create a high fiber density solution.  
4.2.2 Cancer Cell Encapsulation and Culture with Hypoxic and Nonhypoxic 
collagen gels 
KIA was derived from a genetic murine model of sarcoma, LSL-KrasG12D/+; 
Ink4a/Arffl/fl as established previously [40], KIA-GFP was expanded under standard 




penicillin/streptomycin (PS; Invitrogen). For cancer cell encapsulation, we first prepared 
cell pellets of KIA and KIA-GFP cells (7.5 x 105 cells) in a 1.5 mL eppendorf tube. We 
then mixed the pellet with 0.5 mL of collagen solution by gentle pipetting to give a 
homogenous cell suspension. After mixing, the solution is pipetted into a 96 well plate 
(BD Bioscience) and incubated for 30 minutes at 37°C. The nonhypoxic gels were 
created with 50 μL of collagen while the hypoxic gels were made from 100 μL of 
collagen solution. The cells were then cultured within the hydrogel matrices under 
standard culture conditions in DMEM (Dow Corning) with 10% heat-inactivated fetal 
bovine serum (Gibco) and 1% penicillin streptomycin. 200 μL of media was used to 
culture the hypoxic gels and 100 μL was used to culture the nonhypoxic gels.  
4.2.3 Noninvasive and Invasive Oxygen Measurments  
The dissolved oxygen (DO) levels were monitored noninvasively and invasively 
as previously performed[59].  We used a commercially available sensor patch (PreSens) 
for the non-invasive measurements and a Needle-Type Housing Fiber-Optic Oxygen 
Microsensor (PreSens) for invasive measurements. Hydrogel cell constructs were created 
as stated above, and DO measurements were performed on day 3 of cell culture. 
4.2.4 Oxygen Modeling  
The Oxygen Modeling was performed using a previously established method 
[59]. COMSOL Multiphysics (Burlington, Vermont), a commercial finite element 
modeling software was used to evaluate the oxygen concentration in the hypoxic and 
nonhypoxic/atmospheric hydrogels. The values, parameters, and equations are ones 
reported in papers from Gerecht and colleagues [180-182]. Fick’s first law was used to 





     𝐽 = 𝐷∇𝐶 + 𝑅     (Equation 1) 
 
where J is the flux of oxygen in the system, ∇𝐶 is the change in concentration in 
the x, y, and z direction, and R is the cell consumption rate, which is dependent on cell 
type and cell density. The model was verified experimentally. 
4.2.5 Matrix Degreadation and Migration Assays 
DFU To assess the effect of fiber density and oxygen levels on matrix 
degradation, we incorporated 10 μg/mL of DQ Collagen (Invitrogen) into polymer 
solutions when preparing cell suspension as described above. After day 3, the hydrogels 
with DQ-Collagen were observed by fluorescence microscopy (Axio Observer Z1, Zeiss) 
and quantified by measuring the fluorescence intensity using a fluorescence 
spectrophotometer at a wavelength of 495 nm excitation and 515 nm emission (Molecular 
Devices).  
For the 3D cancer cell migration assay, we used a previously developed method 
[59].  Briefly, we encapsulated KIA-GFP cells in hydrogel constructs with different 
oxygen levels. Cells were tracked at day 3 using live-cell 3D confocal microscopy (LSM 
780; Carl Zeiss) equipped with a cell incubator  (37°C and 5% CO2). To optimize the 
experiment properly, only cells that start in-frame were included in the experiment. The 
time-lapse and z-stack images (>200-μm thickness) were collected every 30 min up to 24 
h at 5 randomly selected positions. The images were then analyzed using Imaris spot 
analysis software (Imaris 8.2; Bitplane) to track time-dependent mobility. The 3D 




145]. A minimum of 100 individual cells at each point were tracked to generate x, y, and 
z coordinates at each time point. This data was then sorted to include only cells that were 
present at time 0. From this sorted data, the time that the cells were in-frame was 
calculated, and the most common time was used to select cells for tracking analysis. By 
choosing the time frame with the most visible cells we could maximize the sample size of 
cells that could be analyzed. Finally, velocity and speed profiles, MSDs, and trajectory 
plots were calculated using code adapted from previously established methods [59, 144, 
145] for triplicate tracking trials (n = 3). Statistical analysis was performed using 
MATLAB (Mathworks, Inc.) to calculate the mean, SD, and SE of the mean. A t-test was 
performed where appropriate to determine significance (GraphPad Prism 4.02; GraphPad 
Software, Inc.). Graphed data are presented as average ± SD. Significance levels were set 
at *P < 0.05. 
4.2.6 Reflective Imaging of Collagen Fibers 
During To visualize collagen fibers within a 3D collagen gel reflection confocal 
images were collected using LSM 780  (Zeiss) microscopes. The microscopes are 
equipped with a 40x oil-immersion objective (Zeiss). For reflection imaging, the 
microscope was configured to capture 405 nm light reflected during illumination with the 
405 nm lasers. Reflection microscopy was used for live samples, fiber dimensions and 
pore-size analyses (see below).  
4.2.7 Collagen Fiber Density, Orientation, and Cell Aspect Ratio Analysis 
Collagen fiber density and orientation was adapted from a previously developed 
method using MATLAB (Mathworks)[184]. Collagen fiber width and length were 




and then calculates intensity gradients within subregions of images and uses them to track 
the overall directions of individual. In order to study cell aspect ratio, code was 
developed to fit an ellipse around the cell. The aspect ratio in our sample is a ratio of the 
major to minor axis, in which a perfectly circular cell would have an aspect ratio of one.   
4.2.8 Collagen Gel Morphology and Pore Size Analysis 
For pore size analysis at the nano-scale scanning electron microscopy (SEM) 
imaging was performed using a Hitachi S4700 Scanning Electron Microscope equipped 
with a cold field emission gun operated at 5 kV. Collagen samples were first fixed with a 
routine morphology fixative solution containing 3.0% formaldehyde (Electron 
Microscopy Sciences, 19200), 1.5% glutaraldehyde (Electron Microscopy Sciences, 
16120), 2.5% sucrose (Sigma, S7903), 5 mM calcium chloride (Sigma-Aldrich, C1016), 
5 mM magnesium chloride (Sigma,M8266), and 100 mM sodium cacodylate, (pH 7.4) at 
room temperature for 1 hr. Then, the samples were washed three times with 0.1 M 
sodium cacodylate (Electron Microscopy Sciences,12,300) and 2.5% sucrose (pH 7.4). 
This was followed by quick rinses in deionized water (Milli-Q System) and then 50% 
cold ethanol. After that a series of cold ethanol (Sigma Aldrich, 459836) (70, 90, and 
100%) washes was performed to further dehydrate the sample. After dehydration, the 
samples were washed three times with 100% ethanol at room temperature. Once all 
samples had been fixed, they were supercritically dried using a Samdri-795 supercritical 
point dryer (Tousimis Research Corporation) for 3 hours.  
To reduce surface charge, prior to SEM imaging, all surfaces were coated with 
approximately 12 nm of iridium using a Quorum Q150T ES Sputter Coater.   Prepared 




For pore size analysis at the micro-scale reflection imaging techniques were used as 
stated above. Images were taken at the bottom, middle, and top of the hydrogels in order 
to visual the micron scale pores.  
All pore size analysis was performed using an l ImageJ macro adapted from 
strategies that have previously been used[185, 186].  The script was able to threshold the 
image and then calculate the areas of the gaps between fibers within the image. Those 
gaps were treated as representing the pores in the samples. 
4.2.9 Rheological and Stress Relaxation Analysis 
To analyze matrix stiffness, we performed a rheological analysis of the collagen 
hydrogels using a RFS3 rheometric fluid spectrometer from TA Instruments as we 
previously reported [59, 181]. A time sweep was performed on different fiber density 
hydrogels to monitor the storage modulus (G’) and loss modulus (G’’) at 10% strain and 
a frequency of 0.1 HZ at 37°C. A solvent trap wetter with DI water was used to prevent 
sample evaporation. 
Stress relaxation experiments were performed on RSAG2 dynamic mechanical 
analyzer from TA instruments. The initial elastic moduli and stress relaxation properties 
of collagen gels were measured from compression tests of the gel disks (6 mm in 
diameter, 2 mm thick, equilibrated in PBS for 24 h) (Supplementary Figure 4-1). The 
gel disks were compressed to 10% strain. Stress relaxation under shear mode was 
performed on  an AR1500 EX rheometer from TA instruments.  Collagen gel  disks of 6 
mm in size were used to perform the stress relaxation tests at 0.5% strain for 5 minutes.  




relaxation data in order to compare the time decay constants for different conditions 
(Supplementary Figure 4-2). 
4.2.10 Thermogravimetric Analaysis 
Water content of all samples was analyzed by Thermal Gravimetric Analysis (TGA) 
using the TA Instrument Q5000.  Samples with masses of approximately 30 mg were 
analyzed for weight loss under N2 purge from 25C to 650C at a heating rate of 
20C/min.  The data was analyzed using TA Universal Analysis 2000 Software.   
4.2.11 Statistic Analysis  
Statistical analysis was performed using MATLAB (Mathworks, Inc.) or GraphPad 
(Prism 4.02; GraphPad Software, Inc.) to calculate the mean, SD, and SE of the mean. T-
tests and one way ANOVA were performed where appropriate to determine significance 
(GraphPad Prism 4.02; GraphPad Software, Inc.). All experiments were performed in 
triplicate. Graphed data are presented as averages ± SD. Significance levels are set at *P 
< 0.05. 
4.3 Results and Discussion  
4.3.1 Design of Hypoxic Collagen Gel 
Type I collagen gel has been previously used as a platform to study cancer cell 
migration [187-189]. As collagen is the most abundant ECM component in the body, it is 
critical to better understand how collagen matrix properties affect cancer cell migration 
with and without hypoxic gradients. With our recent findings of   increased sarcoma cell 
migration in hypoxic gradient hydrogels [59, 190], we set out to study how the fibrous 




hydrogel, a better understanding of our system parameters needed to be established. The 
parameters included the diffusion coefficient of our material, boundary conditions, and 
cell oxygen consumption rate. We chose collagen as our matrix due to its fibrous 
structure and a relatively low oxygen diffusion coefficient [191]. It has also been shown 
that collagen fiber density, its post-translational modification, deposition, and degradation 
all can lead to sarcoma cell migration[32, 40, 59, 192].  Next, we had to choose a material 
for the hydrogel to be polymerized in that would allow for close control of the oxygen 
diffusion into the system. By choosing polystyrene, which has a very low diffusion 
coefficient[193], we could create an impermeable barrier on the sides and bottom of the 
hydrogel placed within this common cell culture Petri-dish, thus allowing diffusion of 
oxygen and nutrient from the culture media on the top of the hydrogel. Lastly, the oxygen 
consumption rate needed to be modulated to balance the diffusion of oxygen into the 
system from the media. This oxygen consumption rate is dependent on the concentration 
of the encapsulated cells in the hydrogel. Using these parameters we modelled the system 
using the Fick’s first law, creating an oxygen gradient in the upward direction of the 
hydrogel. To verify the oxygen concentration in the system, KIA-GFP cells were 
encapsulated in the hypoxic and nonhypoxic collagen gels (Figure 4-1A). Using 
reflective microscopy, we verified viability of KIA-GFP cells in the fibrous gel 
constructs (Figure 4-1B).  We measured dissolved oxygen (DO) concentration using a 
non-invasive sensor at the bottom of the hydrogel and found the oxygen concentration 
was at 0.5-2%. We were able to maintain these hypoxic and nonhypoxic oxygen levels 
for 3 days (Figure 4-1C). With this data we built a model using COMSOL Multiphysics, 






Figure 4-1: Establishment of Hypoxic Collagen Hydrogel 
(A) Illustration of hypoxic and nonhypoxic fibrous collagen hydrogels. In order to 
create oxygen gradient the height of the hydrogel- cell constructs was altered. To 




D is the diffusion coefficient of the polymer, dc/dz is the change in concentration per 
change in height, and R is the cell consumption rate. (B) Cells encapsulated in the 
gels are shown using KIA-GFP cells and reflective imaging to visualize the collagen 
fibers. The images were taken at the bottom 300 m of the gel.(C) Non-invasive DO 
readings at the bottom of the hypoxic and nonhypoxic hydrogel-sarcoma cell 
constructs, and compared to the mathematical model. (D) COMSOL was used to 
model the oxygen concentration in the hypoxic and nonhypoxic hydrogels. 
4.3.2 Modulating Collagen Fiber Density Independently of Oxygen Tension 
In addition to establishing the oxygen gradient, the ability to control material 
properties independently from oxygen concentration is key to elucidating the interplay 
between hypoxia and the ECM. Due to this design criteria, a method developed by 
Nguyen-Ngoc et al [194] was chosen to control fiber density independently from collagen 
concentration. The benefit of a constant collagen concentration is the ability to keep the 
availability of cell binding domains constant, independent from collagen fiber density. 
This method includes preparation of the type I collagen solution followed by its 
incubation at 4º C for various time intervals. This low temperature incubation period 
allows collagen fibers to aggregate without crosslinking, resulting in a slower and better 





Figure 4-2: Collagen Fiber Formation  
Schematic showing Collagen fibers aggregate from α-Helix to form fibrils. These 
fibrils aggregate to form larger fibers. Under various low-temperature incubation 
periods, these fibers aggregate to different degrees allowing for the formation of 
high and low density hydrogels.  Drawing not to scale. 
Using this protocol, fiber density could be modulated by incubating the collagen solution 
for 30 minutes to create a low fiber density gel and 2 hours to create a high fiber density 
gel (Figure 4-3A). The density of these collagen fibers per µm2 was quantified using a 
MATLAB script (Figure 4-3A)[184]. In order to verify that fiber density could be 




performed to verify the oxygen concentration along the height of the gel on day 1 and 3 
of culture with KIA cells. From these measurements DO tension in the low and high fiber 
density hypoxic gels ranged from 1-15%, while the nonhypoxic gels ranged from 10-
15%. These measurements show no dependence of oxygen tension on collagen fiber 
density (Figure 4-3B).  
 
Figure 4-3: Decoupling Fiber Density and Oxygen Gradient 
(A) Collagen fiber density can be varied via pre-incubation of collagen solution on 
ice prior to polymerization to create low and high density fiber concentrations: (left) 
SHG images (collagen fibers in green) and (right) fibers quantification (B) Invasive 
DO readings within different regions of the hydrogel showing gradients in the (i) 
low and (ii) high fiber density collagen hydrogels on Day 1 and 3. Scale bars, 25 µm. 






4.3.3 Mechanical Properties of Different Fiber Densities 
To better understand the new hypoxic fibrous collagen gel system, we studied 
their mechanical properties. First, we analyzed the composition of collagen hydrogels by 
TGA. Based on the TGA analysis, the moisture level was found to be approximately 
98.5% and was independent of the sample gelation time (Supplementary Figure 4-3).  
This result shows that the hydrogels have a collagen level of about 1.5% by weight. 
In addition to the moisture content, we analyzed the material properties of the 
collagen gel system. Using reflective microscopy, we first analyzed the fiber thickness 
and length. The higher fiber density collagen gel was found to have wider and longer 
fibers then the low fiber density collagen gel (Supplementary Figure 4-4A-B). We next 
analyzed pore area at micron-scale using reflective microscopy, and found an 
insignificant difference in the pore area (Supplementary Figure 4-4C-E). Pore area at 
nano-scale was quantified using a custom ImageJ macro of SEM images. Interestingly, 
we found that a larger pore area in the higher fiber density collagen gels (Supplementary 
Figure 4-5). These larger pores are due to fiber aggregation in the gel that seems to 
reduce the crosslinking density. This approach thus, allows us to increase the collagen 
pore size at nano-level length scale without altering the number of cell-binding sites, 
since the collagen concentration is the same. Next, we evaluated the elastic moduli of 
both high-density and low-density fiber hydrogels, and observed no difference between 
the two hydrogels (Figure 4-4A). Finally, we evaluated the stress relaxation of the 
material and found the decrease in stress relaxation time of the material is closely related 
to fiber density (Figure 4-4B-C). This decrease in stress relaxation time is most likely 




collagen gel. We speculate this occurs from the collagen -helix aggregation to create 
larger fibers, thus leaving less available monomer for crosslinking. In addition, the stress 
relaxation time is on the same order of magnitude of cell sensing. Wottawah et al. have  
shown rapid structural changes on the order of magnitude of minutes in 3T3 fibroblasts in 
response to mechanical stimulus of laser beams probing for the stress relaxation time of 
the cellular membrane [197]. This quick response to mechano-transduction is further 
elaborated by  Chaudhuri et al which have shown the effect of stress relaxation in 
regulating cell spreading via a yes-associated protein (YAP) [198] and the effect of stress 
relaxation as a key mechanism affecting cell-ECM interactions mediated by adhesion-
ligand binding, actomyosin and contractility[66]. With the structural and mechanical 
properties of the hydrogel established, we next examined the effect of the above 





Figure 4-4: Analysis of Material Properties of Fibrous Collagen Gels.  
(A) Young’s Modulus of the collagen hypoxic hydrogels. (B) With the same elastic 
modulus, the stress relaxation time can be modulated and kept at the same time 
frame as cells. (C) A representative trial of the rheological shear test used to 
determine the stress relaxation time. Scale bars, 2 µm. Significance levels were set at 
*P<0.05. 
 
4.3.4 Sarcoma Cell Migration in Nonhypoxic Collagen Gels at Low and High Fiber 
Concentrations 
With this platform established, we sought to further investigate the effect of O2 gradients 
and mechanical properties on sarcoma cell migration in varying collagen fiber densities. 




cells were encapsulated in the nonhypoxic low and high fiber density gels. Using 
reflective images, we analyzed collagen fibers after the cells were cultured in the 
hydrogels for three days. First, using the MATLAB code, we were able to determine the 
orientation of individual fibers in the gel (Figure 4-5A). We defined aligned collagen 
fibers as fibers that were within a 5% angle from the mean angle of the images. We 
observed that following 3 days of culture, there were more aligned collagen fibers in the 
high fiber density nonhypoxic hydrogels compared to the low density nonhypoxic 
hydrogels (Figure 4-5B). Using those same images, the aspect ratio of the cells was also 
analyzed. We found that the KIA-GFP cells are more elongated in the low fiber density 
nonhypoxic collagen gels and more circular in the high fiber density nonhypoxic collagen 
gels (Figure 4-5C). We could not detect differences in the elastic modulus between the 
two nonhypoxic gels (Figure 4-5D). 
To better understand these differences in fiber alignment and cell morphology in 
the different gels, we next sought to compare collagen degradation and live cell 
movement in the nonhypoxic, low and high fiber density gels. We begun by study the 
protease activity of the encapsulated cells using DQ collagen assay [199]. We found that 
there was no difference in protease activity in the low and high fiber density nonhypoxic 
gels (Figure 4-5E). We observed no difference in the migration speeds between the two 
nonhypoxic gels (Figure 4-5F). Insignificant differences in instantaneous cell velocities 
in the x, y, and z directions were observed between the two nonhypoxic gels (Figure 
5G). By analyzing the mean squared displacement (MSD) in the three planes, we noticed 




baseline values had been established in the system we next sought out to compare these 
observations with GFP-KIA cells encapsulated in the hypoxic collagen gels. 
 
Figure 4-5: Sarcoma Cell Migration in Atmospheric Gradients  
(A) A representative reflective microscopy image showing use of Matlab code to 
analyze fiber alignment and cell aspect ratio. To calculate the aspect ratio, white 
circles were drawn around the cells, green. The aspect ratio was then calculated 
from the major and minor axis of the ellipse. To calculate the fiber angle, yellow 
arrows were drawn along the fibers (in pink), and the angle of the arrows was 
determined. (B) Collagen fiber alignment and (C) cell elongation (aspect ratio)  in 
the two fiber density nonhypoxic constructs after 3 days in culture. (D) Elastic 
modulus of low and high fiber density nonhypoxic gels. (E) Proteolytic degradation 




days in culture.  (F) Overall speed, and  (G) Velocity, and (H) Mean square 
displacement (MSD) in the x, y, and z directions. Plots were created using position 
of KIA-GFP cells in the hydrogels on day 3. Scale bars, 25 µm. Significance levels 
were set at *P<0.05. 
 
4.3.5 Syngersitc effect of sarcoma cell migration of oxygen and fiber density 
We have previously demonstrated that sarcoma cells migrate faster in hypoxic 
gradients [59]. Here, we sought to observe the effects of collagen fiber density and 
viscoelastic  properties on hypoxic sarcoma cell migration.  In order to perform the single 
cell analysis, KIA-GFP cells were encapsulated in hypoxic gradient gels at varying 
collagen fiber concentrations. To control these gradients, an air-oxygenated medium  was 
used to create an oxygen gradient in the upward direction of the hydrogel. Using similar 
fiber analysis as above, we observed that, following 3 days of culture, there were more 
aligned fibers in the lower density hypoxic hydrogel compared to the higher density 
hypoxic hydrogel (Figure 4-6A). This is the opposite of what we observed in the 
nonhypoxic hydrogels (See Figure 4-5B). Interestingly, cells in the higher fiber density 
hypoxic collagen hydrogel were more elongated with larger aspect ratio, compared to the 
spherical cells in low fiber density hypoxic collagen hydrogels (Figure 4-6B). This trend 
is also opposite of the nonhypoxic collagen hydrogels. Similarly to the nonhypoxic 
collagen hydrogels, we could not detect differences in the elastic modulus between the 
two hypoxic gels (Figure 4-6C).  
Using the same approach above, we also explored sarcoma cell protease activity 
and migration in the hypoxic collagen hydrogel. There was a stark increase in protease 
activity in the higher fiber density hypoxic gels compared to the low fiber density 
hypoxic gels (Figure 4-6D). We found that sarcoma cell encapsulated in the higher fiber 




gel (Figure 4-6E). There was an insignificant difference in instantaneous cell velocities 
in the x, y, and z directions (Figure 4-6F). In addition to the increase in cell speed, we 
observed an increase in the MSD of the KIA-GFP cells in the x, y, and z direction, with 
persistent movement in the more fibrous gels (Figure v6G).  The increase in migration 
speed and persistence may explain the difference in fiber alignment and cell elongation in 
the hypoxic collage gels after 3 days of culture.  
Comparing the low fiber density collagen gels, we find higher speed and persistent 
migration of KIA cells in the hypoxic gradients (Supplementary Figure 4-6). 
Comparing the high fiber density collagen gels, we find that KIA cell migrating more 
persistently in the hypoxic hydrogels compared with the nonhypoxic hydrogel 
(Supplementary Figure 4-7). Example trajectories of the cells moving in the various 
conditions (Supplementary Figure 4-8) helped demonstrate that higher fiber density 
hypoxic gel had the most impact on KIA cell migration (Supplementary Table 4-1). We 
also observed that in the hypoxic gradients, matrix fiber alignment is corresponding to 
slower cell migration (and their low aspect ratio), while no fiber alignment is observed 
with rapid cell migration.  The fibers in the high fiber desnity gel were wider and longer 
which could explain why these fibers were less aligned due to their increase in size. 
Compared with previous results [59], we found that the KIA cells migrated slightly 
slower in the hypoxic collagen gels than in the hypoxic gelatin gels. As the hypoxic 
gradients are similar in both of these system cultures, we speculate that the slower 
movement is most likely due to the more fibrous structure of the collagen hydrogels. 




increasing fiber density. We could not detect difference in the direction of movement 
between the low and high fiber density hypoxic gels.  
 
Figure 4-6: Collagen Hypoxic Gel Fiber Density Influences Cell Migration  
(A) Collagen fiber alignment and (B) cell elongation (aspect ratio)  in the two fiber 
density hypoxic constructs after 3 days in culture. (C) Elastic modulus of low and 
high fiber density hypoxic gels.  (D) Proteolytic degradation of the two fiber density 
hypoxic constructs incorporating DQ Collagen for 3 days in culture. (E) Overall 




(MSD) in the x, y, and z directions. Plots were created using position of KIA-GFP 




Previous studies have shown the effect of fiber density [142, 200] and oxygen 
gradients independently on cancer cell migration[59]. Specifically, pathologically, it has 
previously been shown that collagen  fiber density leads to an increase in lymph node 
positive breast cancers metastasis [201], while in sarcomas it has been shown to lead to 
an increase in metastatic potential [40]. Here we elucidate the effects of these cues, by 
engineering collagen gels to control collagen fiber density and its corresponding stress 
relaxation characteristics, as well as  oxygen tension. We found that an increase in 
collagen fiber density enhanced sarcoma cell migration only in hypoxic gradients. In 
agreement with Wottawah et al. who demonstrated cellular responses to mechanical 
stress on the order of magnitude of minutes [197], we show a 3D culture system with a 
similar time to cellular response, most likely mediated by stress relaxation time. Given 
this cellular-applicable stress relaxation time and the fact that the differences in pore size 
are at a smaller length scale than that of the cells, we suggest that an increase in fiber 
density in addition to hypoxic gradients increase sarcoma cell migration. Since the cells 
are migrating faster and to longer distances in the hypoxic high fiber density gels, they 
spend less time modifying the matrix (fiber alignment) and more time moving (cell 
elongation) compared to hypoxic low fiber density gels.  The insights into the stress 
relaxation in the higher fiber desnity gel should be further explored to better understand 




migration seen in a variety of cancer cells such as amoeboid, single or multicellular 
dissemination[202]. 
4.5 Supplementary Information 
 
Supplementary Figure 4-1 Compression stress relaxation of the low and high fiber 
density hydrogels.  
(A) The stress relaxation determined from compression testing of hydrogels. (B) A 
representative trial of the rheological compression test used to determine the stress 





Supplementary Figure 4-2: Example of Maxwell Fits.  









Low (A) and high (B) fiber density collagen gels. The representative trial shows that 
samples had a moisture level round 98.5% by weight. 
 
Supplementary Figure 4-4: Fiber length and width analysis of confocal images. 
Fiber length (A) and width (B) were quantified using MATLAB analysis of 
reflective microscopy images as those shown in Figure 4-3A. The pore area of those 




Supplementary Figure 4-2 at the top, middle, and bottom of the low (C) and high 
(D) fiber density collagen hydrogel. The overall pore area was also determined (E). 
Significance levels were set at  ****P<0.0001. 
 
Supplementary Figure 4-5: Pore area analysis sequence from SEM images.  
(A) Original image is cropped. (B) Pores are segmented using Phansalkar auto local 
thresholding with a radius of 15 pixels and smoothed by performing morphological 




pores are overlayed onto original image. (E) Scanning electron microscopy (SEM) 
images of the low and high fiber density gels, showing an increase in pore size as 
fiber density increases. Significance levels were set at **P<0.01. 
 
Supplementary Figure 4-6: Comparison of low fiber density gels.  
(A) Velocity, overall speed, and (B) Mean square displacement (MSD) in the x, y, 
and z directions. Plots were created using position of KIA-GFP cells in the low fiber 
density hydrogels on day 3. 
 




(A) Velocity, overall speed, and (B) Mean square displacement (MSD) in the x, y, 
and z directions. Plots were created using position of KIA-GFP cells in the high 
fiber density hydrogels on day 3. 
 
Supplementary Figure 4-8: Trajectories of sarcoma cells.  
Trajectories generated by Imaris used to track cells moving in three-dimensional 
space. The color of the trajectory green to red indicates time with purple being the 
earliest and red being the latest time-point. Scale bar is 100 m. 
 
Supplementary Table: 4-1: Summary of results* 







Low Fiber Density 
Nonhypoxic Gel 1 3 1 1 2 2 
Low Fiber Density 
Hypoxic Gel 4 1 3 2 3 3 
High Fiber Density 
Nonhypoxic Gel 3 2 2 3 1 1 
High Fiber Density 
Hypoxic Gel 2 4 4 4 4 4 






5 Quicker Stress Relaxation Time Increases 




Cell migration through the extracellular matrix is a key factor in the disease 
progression of cancer. There are a plethora of factors that have been linked to cancer cell 
migration such as oxygen[59, 70] and crosslinking of the extracellular matrix (ECM)[40]. 
Specifically in sarcoma an increase in procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 
(PLOD2) has been shown with more a more metastatic phenotype[40, 42]. The ability to 
experimentally recapitulate these factors in an in-vitro platform is especially difficult, as 
the biophysical and biochemical properties of native ECMs are hard to control. Collagen 
is one of the most abundant ECM matrix proteins[203], and increased levels of collagen 
have led to increases in sarcoma cell migration[40, 70].  In addition to extracellular 
matrix components, oxygen gradients are a key factor of the tumor microenvironment. 
Intratumoral hypoxia occurs when oxygen drops below 5%. As tumors rapidly outgrow 
their blood supply they create an oxygen gradient in the developing site. This oxygen 
gradient has been revealed to increase cell migration in hypoxia[40, 59, 70] compared to 





Hydrogels are commonly used to recapitulate a three-dimensional (3D) cellular 
microenvironment. These scaffolds are typically composed of synthetic or naturally 
occurring materials.  These materials seek to mimic the chemical and physical properties 
of the tumor microenvironment as well as the ECM. In viscoelastic materials such as the 
ECM, stress relaxation is a key property of the matrix. It has previously been shown that 
different cancers have unique stress relaxation profiles[67]. Stress relaxation, or the rate 
at which materials deform under force, is an understudied viscoelastic property of ECM 
proteins. Few studies have investigated the effect of stress relaxation on cell behavior[68-
71] and particularly in cancer. Stress relaxation has been revealed to affect numerous 
behaviors, including cell motility[72], mesenchymal stem cell differentiation [66], and 
the cell’s ECM sensing capability [73]. Since changes in the ECM have been revealed to 
decrease survival rates in many cancers[204], we sought to explore the effect of stress 
relaxation on cancer cell migration and tumorigenesis.  
When designing a novel hydrogel matrix, in order to assay biological functions, it 
is important to make sure the control and experimental conditions have similar properties 
such as stiffness,  pore size[177, 178]  and fiber density[142, 174] in order to properly 
mimic the cellar microenvironment. We have previously demonstrated the importance of 
collagen in sarcoma cell migration[70], however it is very difficult to alter a single 
mechanical property in collagen gels without drastically changing the  collagen fiber 
structure, pore size, and binding site density. In this study, we have developed a novel 
method to control stress relaxation independently of collagen fiber density, collagen 
stiffness, and oxygen concentration, in order to explore the ability for stress relaxation 




platform, collagen fiber density was controlled by standardizing ice incubation times 
prior to polymerization. After polymerization, microbial transglutaminase (mTG) was 
added to modulate the stress relaxation time of the hydrogel without modulating the 
collagen architecture. This methodology allowed us to maintain the structure of the 
collagen, as confirmed by reflective, scanning electron, and transmission electron 
microcopy without altering the stiffness of the matrix. In addition, oxygen concentration 
could be controlled as previously developed[70]. The combinatory effect of these 
conditions allowed, for the first time, to explore the synergistic effect of stress relaxation 
in oxygen gradients comprised of 100% pure collagen structures. Using murine 
undifferentiated pleomorphic sarcoma cells (KIA) and primary patient undifferentiated 
pleomorphic sarcoma cells (hUPS), we found that quicker stress relaxation time in 
oxygen gradients led to increase speed of sarcoma cell motility via procollagen-lysine,2-
oxoglutarate 5-dioxygenase 2 (PLOD2), with the quicker stress relaxation stimulating 
PLOD2 via transforming growth factor beta (TGF-). Finally, upon implanting the 
quicker and slower stress relaxation hydrogels in a murine model, there was a significant 
increase in tumor growth once implanted; as well as an increase in PLOD2 expression 
and collagen secretion in the quicker stress relaxation hydrogel.  
5.2 Materials and Methods 
5.2.1 Cell Culture and Primary Tumor Cell Extraction 
KIA was derived from murine model of sarcoma, LSL-KrasG12D/+,Ink4a/Arffl/fl as 
established previously[40]. KIA-GFP was expanded under standard culture conditions in 
high glucose DMEM with 10% FPBS and 1% penicillin/streptomycin. hUPS cells were 




Mathason. hUPS cells were extracted by incubating the primary tumor with a 3 mg/mL 
collagenase solution in DMEM for 45 min at 37C. The tumor was then spun down and 
the supernatant was aspirated and replaced with 0.05% trypsin EDTA solution and again 
incubated for 15 minutes at 37C. The digestion is then stopped with complete cancer 
media. The tumors again were spun down, aspirated, and replaced with serum free media. 
The tumor is washed 2 more times and then triturated through a 40 μm cell trainer into a 
50 mL conical tube. The cells are then spun down and plated. Cells were selected by 
continuous culture for up to 8 passages prior to use. 
5.2.2 Collagen Gel Preparation and Cell Encapsulation 
Collagen gel was prepared as previously reported[70]. In short, to make 1 mL of 3 
mg/mL collagen solution, 35.96 μL of M199 10× medium (Thermo Fisher Scientific) was 
mixed with 11.51 μLof1M NaOH until it turned dark pink. Next, we used acid soluble rat 
tail collagen I at 9.61 mg/mL (Corning #354249). A total of 312 μL of collagen was 
added to the dark pink solution and mixed thoroughly. A total of 640.35 μL of M199 1× 
medium (Thermo Fisher Scientific) was then mixed with the solution to create our final 
collagen gel solution. The solution was then incubated on ice for 2 hours. For cancer cell 
encapsulation, we first prepared cell pellets of hUPS-GFP and KIA-GFP cells (7.5 × 105 
cells) in a 1.5 mL eppendorf tube. We then mixed the pellet with 0.5 mL of collagen 
solution by gentle pipetting to give a homogeneous cell suspension. After mixing, the 
solution was pipetted into a 96 well plate (BD Bioscience) and incubated for 30 min at 37 
°C. Non-hypoxic gels were made with 45 μL of collagen and hypoxic gels were made 




To alter the stress relaxation, gels were incubated with PBS or 24 mg/mL 
microbial transglutaminase (mTG) for 2 hours at room temperature. After 2 hours, the 
solutions were aspirated and the gels were cultured in normal culture media. 200 μL of 
media was added to the hypoxic gels and 100 μL was added to the non-hypoxic gels. 
5.2.3 Noninvasive and Invasive Oxygen Measurements 
Dissolved oxygen levels were monitored non-invasively and invasively as 
previously reported[59, 70]. A commercially available sensor patch (PreSens) and a 
Needle-Type Housing Fiber-Optic Oxygen Microsensor (PreSens) were used for the non-
invasive and invasive experiments respectively. Hydrogels were prepared as stated above 
and oxygen measurements were performed on day 3.. 
5.2.4 Matrix Degradation  
Degradation of the matrix was performed as previously published[70] by 
incorporating 10 μg/mL of DQ collagen (Invitrogen) into polymer solution prior to cell 
encapsulation. On day 3 DQ Collagen was analyzed by fluoresce microscopy (Axio 
Observer Z1 Zeiss) and measured using a fluorescence spectrophotometry at a 
wavelength of 495 nm excitation and 515 nm emissions (Molecular Devices). 
5.2.5 Cell Tracking and Drug Treatment 
For cell tracking, a previously developed method[59, 70, 205] was used to assess 
sarcoma cell migration.  KIA-GFP cells were encapsulated in hydrogels with different 
oxygen levels and mTG treatment.  On day 3, cells were tracked with live-cell 3D 
confocal microscopy (LSM 780; Carl Zeiss) equipped with an incubator (5% CO2 and 37 




minutes up to 24 hours at five randomly selected positions.  Cells that did not start in 
frame were not included in the analysis in order to properly optimize the experiment.  
The images were analyzed with Imaris spot analysis software (Imaris 8.2; Bitplane).  The 
3D migration analysis was performed with a previously developed strategy[59, 70, 205].  
A minimum of 100 individual cells were tracked to generate x, y, and z coordinates at 
each time point.  These were then sorted to only include cells present at time 0.  The time 
that each of the sorted cells were in frame was calculated and the most common time was 
used to pick cells for tracking analysis, maximizing the sample size of cells in the 
analysis.  Velocity, speed and Mean Squared Displacements were calculated using code 
adapted from previously established methods for triplicate tracking trials (n=3)[59, 70, 
205].  The statistical analysis was performed using MATLAB (Mathworks, Inc.) to 
calculate the mean, SD, and SE of the mean.  Where appropriate, a t test was performed 
where appropriate to determine significance (GraphPad Prism 4.02; GraphPad Software, 
Inc.).  Graphed data are presented as average ± SD.  Significance levels were set at 
*P<0.05. 
For minoxidil and TGF-  inhibitor treatment, cells were cultured in hydrogels 
under the conditions and methods described above for 3 days.  On day 3, 0.5 mM 
minoxidil or 10 M TGF-  inhibitor dissolved in KIA cell culture media was added to 
the wells containing the hydrogels and the cells were tracked for 24 hours. Untreated 





5.2.6 Rheology and Stress Relaxation Analysis 
For all rheological experiments an AR1500EX rheometer (TA Instruments) was 
used. A time sweep was performed on the mTG and control gels at 1% strain and 10 Hz 
to monitor the storage (G’) and loss modulus (G’’) at 37C. A solvent trap with DI water 
or an immersion cup with PBS was used to prevent evaporation. Stress relaxation 
experiments were performed for strains from 0.5%-1% for 2 minutes. As previously 
reported a single element Maxwell model was used to fit the stress relaxation 
constants[70]. Frequency sweep was performed at 1% strain from 0.5 to 10 Hz to study 
the change in moduli in response to increasing frequency. Creep and recovery test was 
also performed. All samples were initially stressed at 10 Pa and relaxed for 2 minutes 
followed by a strain recovery test. In the strain recovery test the applied stress was 
removed and strain was monitored over time. A four element Maxwell-Voight model was 
used to fit the relaxation constant as previously performed[206]. A stress strain curve was 
generated by getting the corresponding stress value at a given strain.     
5.2.7 Second Harmonic Generation and Reflective Microscopy 
In order to study collagen fibers in collagen gels reflective microscopy was used. 
Images were collected using a LSM 780 (Zeiss) microscope. A 40x oil immersion 
objective was used to capture the images and were configured to use the 405 nm light to 
illuminate and be collected to visualize the collagen fibers. Second harmonic generation 
(SHG) microcopy was carried out with a LSM 510 (Zeiss) microscope equipped with a 
Chameleon Ultravision II Laser Module (Coherent). A wavelength of 810 nm was used to 




examining collagen in the murine tumors, H and E slides were imaged using SHG 
microscopy.   
5.2.8 Collagen Fiber Morphology, Orientation, and Cell Aspect Ratio Analysis 
Collagen fiber orientation was adapted from a previously developed method using 
MATLAB (Mathworks)[70].  Collagen fiber width and length were analyzed using a 
previously established method[70].  The software segments the image and calculates 
intensity gradients within subregions of images and uses them to track the overall 
directions of fibers.  To study cell aspect ratio, code was developed to fit an ellipse 
around the cell and the aspect ratio is the ratio of the major to minor axis.   
5.2.9 Scanning Electron Microscopy 
Collagen hydrogels, with and without cells, were fixed as previously described 
and processed for conventional scanning electron microscopy[207].  
Briefly, dime-size gels were fixed in 100mM cacodylate buffer, pH 7.4, 
containing 3% formaldehyde, 1.5% glutaraldehyde, and 2.5% sucrose for 1 hr, washed, 
and osmicated at 4˚C in Palade’s fixative containing 1%OsO4.  Cells were then 
dehydrated through a graded series of ethanol; critical point dried using a Tousimis 
Model 795 critical point dryer (Rockville, MD); and coated with 4nm platinum using a 
Anatech Hummer 6.1 sputter coater (Hayward, CA). Samples were imaged in an FEI 
Quanta 200 ESEM (Hillsboro, OR) using the Everhart-Thornley secondary electron 





5.2.10 Transmission Electron Microscopy 
Collagen hydrogels, with and without cells, were fixed as previously described[207]. 
Briefly, for conventional electron microscopy (EM), gels were fixed in 100mM 
cacodylate buffer, pH 7.4, containing 3% formaldehyde, 1.5% glutaraldehyde, and 2.5% 
sucrose for 1 hr, washed; and osmicated at 4˚C in Palade’s fixative containing 1%OsO4.  
Cells were then washed; en bloc stained with Kellenberger's uranyl acetate over night; 
dehydrated through a graded series of ethanol; and subsequently embedded in epon. 
80nm sections were cut on a LEICA UCT ultramicrotome;collected onto 300 mesh 
formvar/carbon coated grids; and post-stained in uranyl acetate and lead citrate. .  Images 
were recorded using a Soft Imaging System Magaview III camera mounted on a Tecnai 
12 TEM operating at 100keV; and figures were assembled in Adobe Illustrator. 
5.2.11 RT-PCR 
A quantitative real-time RT-PCR assay was used to assess gene expression.  Total 
RNA was extracted from cells encapsulated in hydrogels with TRIzol (Invitrogen) in 
accordance with manufacturer instructions.  Hydrogels were placed in 500 μL of TRIzol 
and homogenized with a microhomogenizer.  The suspension was then centrifuged at 
12,000 x g for 15 min and the supernatant was separated.  100 μL of chloroform was 
mixed with the solution by manual agitation for 20 s and the mixture was centrifuged at 
12,000 x g for 10 min.  The supernatant was isolated and mixed with 250 μL isopropyl 
alcohol and kept at -4 °C for 1 h.  The precipitates were separated by centrifugation at 
7,500 x g for 5 min and washed with 70% ethyl alcohol.  Total RNA was quantified using 
an UV spectrometer and validated by lack of DNA contamination.  One microgram of 




from Promega), according to the manufacturer’s instructions.  TaqMan Universal PCR 
MasterMix and Gene Expression Assay (Applied Biosystems) was used according to the 
manufacturer’s instructor for PLOD2, MMP2, MMP9 and HPRT1. 
5.2.12 TCGA Analysis 
Gene Expression Profiling Interactive Analysis (GEPIA)[208] was used to 
generate survival curves as well as study trends in RNA-sequence data, based of querying 
the cancer genome atlas database. GEPIA also generated and provides all the statistics.  
5.2.13 Generation of GpNLuc KIA stable cell lines 
KIA cells (70% confluent) were transfected with pRetroX-Tight-MCS_PGK-
GpNLuc (Addgene plasmid #70185) using Lipofecatime 2000 (Thermofisher scientific) 
in serum free medium as per the manufacturer’s instructions. Mixed populations were 
then FACS sorted for high GFP signal using a Sony Biotechnology SH-800 'chip' cell 
sorter at one cell per well in a 96 well plate. Stably expressing clonal populations were 
then utilized for downstream experiments.  
5.2.14 In-vivo and IVIS Imaging 
KIA cells, expressing GFP or GpNLuc that were encapsulated in quick and slow 
stress relaxation hydrogels as reported above, were subcutaneously implanted in 8-10 
week in nude mice. Caliper measurements were performed to track subcutaneous tumor 
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where V is the volume of the tumor, L is the major axis, and W is the minor axis of the 




with 20 g/mL of furimazine followed by luminescence imaging with IVIS Spectrum 
(PerkinElmer) within 5 minutes of injections. Average radiance (photons per second per 
centimeter squared per steradian) was monitored at each time point and tumor.   
5.2.15 Histology and Immuno-fluorescent Staining 
For murine tissue, following fixation the tissue was dehydrated with serial ethanol 
(70%-100%); embedded in paraffin; 5 m sections were cut; and subsequently treated 
with hematoxylin and eosin (H and E) stain, mason trichrome, or PLOD2. 
Immunofluorescent stains were performed as previously reported on gels[205]. SMAD2 
(Proteintech), vinculin (Sigma), phaloidin, and YAP (SantaCruz) were all used at a 1:200 
dilution and counterstained with DAPI. An anti-rabbit Alexa Fluor 564 (Life 
Technologies) was used at 1:500 dilution and imaged with Zeiss LSM 780 or LSM 800 
microscope. PLOD2 (Proteintech) was also used at 1:200 dilution for histology sections.   
5.2.16 Histological, SEM, TEM, and Immuno-fluorescent Quanitificaiton 
Histology stains were quantified as previously reported[209]. In short background 
was taken from an empty portion of the slide, the color deconvolution plug-in ImageJ 
(National Institutes of Health) was used to extract the DAB color of the image. Finally, 
the mean intensity was calculated from the DAB intensity over the entirety of the image.  
SEM images cells moving through the hydrogel were analyzed using ImageJ. The 
pore area was measured by drawing a region of interest over the pore. ImageJ was also 
used to measure the bands in TEM images of the collagen fibers.  
For SMAD2 quantification IMARIS (Bitplane) was used to find the colocalization 
of SMAD2 and DAPI from a z stack of the cells. Surface area of the colocalization 




5.2.17 Statistical Analysis 
Statistical analysis was performed using MATLAB (Mathworks, Inc), or Prism 4 
(GraphPad Software, Inc.) to calculate the mean, standard deviation, and standard error 
mean. T test and one way ANOVA were perfumed where appropriate to determine 




5.3 Results and Discussion 
5.3.1 Design of Stress Relaxation Collagen Gel 
Collagen gels have been a standard platform for cancer cell research and 
migration for many years[70, 177, 201].  Recently, we have explored how to create 
complex hypoxic collagen gel scaffolds in order to explore the roll that fiber density 
plays on sarcoma cell migration[70]. In the previous version of the platform, stress 
relaxation time was the one difference between the low and high fiber density hypoxic 
gels; with the low fiber density having a slower stress relaxation time as compared with 
the high fiber density. In the present study, we explored the effect of stress relaxation, 
independently of collagen fiber density and architecture, on cell migration in oxygen 
gradients.  
Briefly, to establish the hypoxic hydrogel, we balance the diffusion coefficient of 
the material, boundary conditions, and cell concentration. Collagen was chosen due to its 
low oxygen diffusion coefficient[70]; polystyrene was chosen as well due to its low 
oxygen diffusion coefficient; and the cell concentration was chosen to balance the oxygen 
diffused in from the media. To control the collagen fiber density, the collagen solution 
was kept at 4°C for two hours[70]. This allows for collagen fibers to aggregate without 
crosslinking. In order to initiate crosslinking,  gels were formed at 37°C. This allows for 
the collagen fibers to entangle and the hydrogel to be formed. Once the hydrogel 
structure was established, microbial transglutaminase was used to crosslink further 
crosslink collagen fiber bundles. 24 mg/mL microbial-transglutaminase (mTG) was 
chosen to allow for crosslinking of collagen fibers as a means to change stress relaxation 




the stress relaxation time coefficient decreased by a half order of magnitude (Figure 5-
1B-C). The stress relaxation was also verified using a creep and stress; and relaxation test 
(Supplementary Figure 5-1A-B); and a similar decrease in stress relaxation was 
observed. Furthermore, the different hydrogels response to frequency was evaluated to 
explore a difference in slope, which is correlated with differences in stress relaxation 
(Supplementary Figure 5-1C-D). Finally, to fully characterize the material properties, 
the stress versus strain curve was plotted to determine the differences in hydrogel 
properties that result from a change in stress relaxation (Supplementary Figure 5-1E).  
In order to further characterize the hydrogel scaffold, reflection microscopy, 
scanning electron microscopy (SEM), and transmission electron microscopy (TEM) were 
performed on the mTG hydrogel and the control. From reflective microscopy, TEM, and 
SEM results, no visible difference between the two hydrogel structures can be detected 
(Figure 5-1D).  Additionally, TEM revealed no significant difference in the light and 
dark segments of the collagen fibers (Figure 5-1D-E). We thus conclude, from these 






Figure 5-1: Material properties of collagen stress relaxation gels.  
A.) Stiffness of the two hydrogels are the same, while the stress relaxation time (B,C) 
quickens with the addition of mTG. D.) Reflection, scanning electron microscopy 
(SEM), and transmission electron microscopy (TEM) displayed no difference in the 
structure of the hydrogels with the addition of mTG. E.) The length of the light and 
dark chains from the TEM images to demonstrate no difference in the light and 




5.3.2 Morphology and Migration of Cells in the Stress Relaxation Hydrogels 
Having established the hydrogel platform, the influence of stress relaxation on 
sarcoma cell migration was explored in both hypoxic and non-hypoxic gradients. This 
was investigated using KIA cells, a mouse undifferentiated pleomorphic sarcoma line. 
KIA cells (Figure 5-2A) displayed an increase in the cell spreading in both hypoxic and 
atmospheric mTG gels. The hypoxic gradient was measured for both cell lines in the 
collagen gels on day 3 (Figure 5-2B). Further analysis of the cell morphology displayed 
an increase in the aspect ratio of cells in the quicker stress relaxation conditions, such as 
the mTG hypoxic conditions (Figure 5-2C). We have previously demonstrated that a 
large aspect ratio is consistent with a more migratory cells phenotype[70]. 
KIA cell were tracked on day 3 of culture using IMARIS and MATLAB. From 
this analysis, there is a minimal increase in cell migration for the KIA cells in 
atmospheric conditions (Figure 5-2D). In the hypoxic gradient, however, there is a slight 
increase in the cell migration in the x and y directions, but a significant increase in the z 
direction in the mTG gels (Figure 5-2E); and there were minimal changes in the 
instantaneous cell velocities in the different conditions (Supplementary Figure 5-2A-B). 
In addition, the fiber alignment was analyzed using previously established methods[70] 
(Supplementary Figure 5-2C). From this analysis, a slight increase in fiber density was 





Figure 5-2: Sarcoma cell migration increases with the quicker stress relaxation time 
in hypoxia.  
A.) Representative photos of the KIA cells in hypoxic and atmospheric hydrogels 
with two different stress relaxations. B.) Oxygen gradients on day three for the 
hypoxic and atmospheric hydrogels with KIA cells. C.) The aspect ratio of the KIA  
cells D.) Migration of KIA cells in the atmospheric hydrogels on day 3 displaying 
minimal difference in migration. E.) Migration of the KIA cells in hypoxic hydrogel 




5.3.3 PLOD2 Increase in mTG Gels 
In order to better understand the cause for an increase in cell migration, cellular response 
in mTG gels was investigated. It has been demonstrated that TGF- signaling initiates 
SMAD2/3 nuclear localization and has been linked to an increase in collagen cross-
linkers, such as procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2) [210-212]. 
Specifically, in breast cancer TGF- and SMAD2/3 have been linked to cell mechano-
sensing and in stiffer matrixes there is an increased in the expression of SMAD2/3 [213]. 
In pancreatic cancer TGF- increase leads to more migratory cells[214] and induced 
epithelial to mesenchymal transition in cervical cancer as well an increase in patient 
mortality[215]. In order to explore TGF-  and SMAD2/3 signaling the different 
hydrogels were stained for SMAD2 to observe nuclear localization (Figure 5-3A). Using 
3D images of cells the surface area SMAD2 at nucleus was calculated. There is a 
significant increase in SMAD2 localization in the mTG hydrogels. From this increase in 
SMAD2 we sought to explore the increased effect of PLOD2 signaling. From previously 
published works, procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (PLOD2) has been 
demonstrated to be a key factor in sarcoma cell migration, especially in hypoxia[40, 59]. 
Using PCR an increase in PLOD2 expression was observed in the mTG gel, both in 
hypoxia and atmospheric conditions as well as in the control hypoxic gel (Figure 5-3B). 
The increase in PLOD2 expression in the hypoxic condition is similar to what we have 
previously demonstrated[40, 59]. In addition the increase in the mTG atmospheric 
condition is similar to what was observed in other cells lines that have increased TGF- 
signaling[210]. In the mTG hypoxic gels we observe a combinatory effect TGF- and 




confirm that the PLOD2 expression is linked to TGF-  signaling in the mTG treated 
gels, PCR was performed (Figure 5-3C). mRNA expression of the mTG hypoxic gel 
returned to the same level as the control hypoxic gel and the mTG atmospheric gel had 
similar PLOD2 expression as the control atmospheric gel. This demonstrates that the 
increase in PLOD2 is due to TGF-.  
Furthermore, to explore confounding factors, there was no difference in the number of 
vinculin spots, indicative of focal adhesions (Supplementary Figure 5-3A). This 
indicated that the cell interaction with the matrix is relatively the same amongst all four 
conditions. The amount of actin fibers present was also the same in all four conditions 
(Supplementary Figure 5-3A). Actin rearrangement and localization has been 
demonstrated as a factor in mechanotransduction pathways[216]. Finally, to study 
mechanical sensing via the yes-associated protein (YAP) pathway, immunofluorescent 
imaging was performed. YAP has been observed as a key molecule in cell mechano-
sensing when localized to the nucleus[217].  However, in our study YAP localization was 
present only in the cytoplasm in all four conditions (Supplementary Figure 5-3A) 
displaying that it is not active; this is most likely due to the fact that the hydrogels are 
roughly 100 Pa (Figure 5-1A). 
To explore at the consequences from the increase in PLOD2 expression, SEM images of 
mTG and control hypoxic gels to explore how the cells interact or pull on the matrix. 
From these images, we demonstrate that the cells are creating larger pores in the mTG 
treated gels (Figure 5-3D). This is most likely due to the cells pulling on the fibers. To 
confirm that the pathway was not protease mediated, PCR was performed to explore the 




no significant difference in MMP2 mRNA expression. In order to confirm whether there 
was a difference in protease activity amongst the different conditions at the protein level 
a DQ collagen assay was performed. There was no difference in the normalized RFU 
values, which correlates to protease secretion, amongst all four conditions 
(Supplementary Figure 5-4B). Using fluorescent microscopy, the study displayed 
minimal differences in the localization of the proteases, with the majority of protease 
localization amongst the circular cells in the gels (Supplementary Figure 5-4C).  
To further explore the cell behavior change due to an increase of PLOD2 a variety of 
tracking studies were performed with a PLOD2 knockdown line as well as normal KIA 
cells treated with minoxidil[40, 59] or TGF-  inhibitor. From these experiments, we 
observed no difference in the migration of the KIA cells in hypoxic gradients in the z 
direction when PLOD2 was knockdown or inhibited specifically with minoxidil (Figure 
5-3E). It was also observed that these studies dropped the migration speeds below the 
hypoxic control gel. In addition, when TGF-  inhibitor was added the mTG hydrogel 
and control hydrogel ended up having the same MSD trend as the untreated control 
hypoxic gel (Figure 5-3E) This demonstrates that the increase in migration in the mTG 
gels is from an increase in PLOD2 caused by TGF-  stimulation. From these results, 
there is a clear correlation with PLOD2 expression and stress relaxation, and the 







Figure 5-3: Biochemical and Biomechanical ques from stress relaxation hydrogels 
(A).SMAD2 nuclear localization in KIA cells cultured in mTG and control hydrogel 
sin hypoxic and atmospheric conditions. (B). Quantification of SMAD2 localization 
to nucleus. (C). PLOD2 expression of KIA cells treated with and without TGF- 
inhibitor. (D). SEM images of the KIA cells cultured mTG and control hypoxic gels, 
characterizing the pore size that cells migrate through. (E).Means squared 
displacement in the z direction of KIA cells in hypoxic mTG and control gels treated 
having PLOD2(-). 
5.3.4 Stress Relaxation Hydrogel Leads to Increase in Tumorigenesis 
In order to recapitulate the importance of PLOD2 in an animal model, mTG and 
control hydrogels were implanted subcutaneously (Figure 5-4A). KIA cells transfected 
with a bioluminescent resonance energy transfer (BRET) reporter was used for all in-vivo 
experimentation[218]. Tumors were allowed to grow for up to 20 days before euthanasia, 
and monitored using IVIS imaging (Figure 5-4B), displaying enhanced fluorescent signal 
over time in mTG gels compared to the control gels. This was also correlated with an 
increase in tumor volume (Figure 5-4C).  
With the increase in tumor size we decided to study the collagen fiber architecture 
in the tumor using second harmonic generation (SHG) microcopy (Figure 5-4D). The 
images indicate a dramatic increase in collagen secretion in the tumors (Figure 5-4E). In 
addition, images were analyzed using ct-FIRE code suite[185], which allows for the 
analysis of multiple parameters of collagen fibers, such as width and length. Using 
images taken of the mTG and control tumors we detected an increase in collagen fiber 
width and length in the mTG tumors (Figure 5-4E). This increase in collagen density is 
similar to what has been previously demonstrated (Eisinger et al) when PLOD2 is 
modulated[40]. To confirm the increase in collagen expression mason trichrome was 
performed and there is an increase in collagen fibers in tumors grown from mTG 




Using a previously established method[209] PLOD2 intensity was calculated. There was 
a significant increase in PLOD2 expression in mTG tumors. This in-vivo work 
demonstrates how the quicker stress relaxation and increase in PLOD2 expression 










Figure 5-4: Tumor growth and collagen express in quicker stress relaxation tumors 
(A). Schematic of in-vivo experiments, by subcutaneously implanting hydrogels. (B) 
IVIS imaging was used to image tumor growth and cell density via a BRET reporter 
and fluorescent intensity  (unit is in radiant efficacy). (C) Tumor volume was 
measured to track the growth of mTG and control tumors. (D) Second harmonic 
generation microscopy was used to study collagen fiber density in day 20 tumors. 
(E). ct-FIRE analysis was used to analyze collagen fiber width, length, and percent 
collagen area. (F). Mason trichrome stain for day 20 tumors grown from gels 
implanted subcutaneously. The arrows are pointing to collagen fibers in the 
sections. (G). PLOD2 stain of day 20 tumors. DAB intensity was quantified 




5.3.5 TCGA Analysis and Patient Relevance of High PLDO2 Expression 
To study the clinical significance of PLOD2 expression in sarcoma, the cancer 
genome atlas (TCGA) database was queried to study survival rates as well as correlations 
from patient RNA-seq data. 261 patients were queried and the results were pooled using 
GEPIA to generate RNA-seq correlations, disease free survival, and overall 
survival[208]. Firstly, we explored the correlation between upregulation of SMAD2, 
TGF-, and hypoxia inducible factor 1-alpa (HIF1-) with PLOD2, and a significant 
Pearson correlation between the each of the two genes in sarcoma patients (Figure 5-5A). 
HIF1- is one of the key factors that is up-regulated in hypoxia[219]. This is expected 
given our previous results displaying the effect of hypoxia on PLOD2 expression[40, 59]. 
Additionally, we also observed a correlation between PLOD2 and SMAD2 as well as 
PLOD2 and TGF-. This was expected based off of the data in Figure 3. Secondly the 
disease-free survival data was queried and graphed (Figure 5-5B). When SMAD2 TGF-
, or HIF1- expression was used to segment survival data there was no significant 
change in mortality and disease-free survival. However, when PLOD2 expression was 
used partition survival data there is a significant decrease in survival with and 
upregulation of PLOD2. Finally, when overall survival was explored there was a 
significant increase in mortality rates of patients from 40% for low expressing PLOD2 to 








Figure 5-5: TCGA Data:  
(A). RNA-seq correlation of TCGA data of expression of SMAD2, TGF-, HIF1- 
with PLOD2 (B) Disease free survival and overall survival of patients from TCGA 
database displaying no difference in survival in relation to the expression of 
SMAD2, TGF-, or HIF1-  and increase in survival with lower expression of 
PLOD2. 
To further confirm the TCGA data we explored the ability for the mTG hydrogel 
platform to explore the response of primary patient undifferentiated pleomorphic sarcoma 
cells (hUPS). In the different hydrogels, we observed distinct phenotypes in the different 
gels (Supplementary Figure 5A). The oxygen profiles in the gels on day 3 were similar 
to the KIA cells (Supplementary Figure 5B). We also observed an increase in aspect 
ratio in the more migratory cells (Supplementary Figure 5C). Finally, when the 
migration was studied, there is no difference in the atmospheric conditions 
(Supplementary Figure 5D), but there was a significant increase in migration in the 
mTG hypoxic gel condition compared to the control hypoxic gel in the z direction 
(Supplementary Figure 5E). There was no difference in the velocity and fiber alignment 
of hUPS cells in the hydrogels (Supplementary Figure 6A-C). From this data we can 
demonstrate the predictive power of our platform to explore a more migratory phenotypes 
in primary human samples. 
5.3.6 Proposed Biological Response to Quicker Stress Relaxation Hydrogels 
From our above study we propose a mechanism for cellular response to quicker stress 
relaxation (Figure 5-6), in which hypoxia induces PLOD2 expression via HIF1- 
upregulation. This increase in crosslinking yields a quicker stress relaxation of matrix 
which in turn stimulates TGF- and therefore SMAD2 nuclear localization which causes 





Figure 5-6: Proposed biological response to quicker stress relaxation:  
HIF1- upregulation due to hypoxia increases PLOD2 expression causing a quicker 




The current study demonstrates the importance of stress relaxation as a new 
potential mechanical property that should be further explored in cancer research. The 
novel collagen hypoxic hydrogel platform was used to explore this mechanical property. 
The platform allows us to control oxygen and stress relaxation without altering the micro 
and nano-scale collagen fiber architecture, allowing us to create a truly in vivo mimicking 
platform to study finite properties of the tumor micro-environment. From our studies, we 




hypoxic hydrogels, with the quickest stress relaxation, had the greatest mean squared 
displacement, as well as a more elongated phenotype and aspect ratio. 
In order to explore the molecular mechanisms behind the faster cell migration, we 
were able to deduce that the quicker stress relaxation increased PLOD2 expression in 
cells via TGF- and SMAD2. This increase in PLOD2 had an additive effect when 
coupled with hypoxia. When the quicker stress relaxation hydrogels were implanted into 
a mouse, there was an increase in tumor cell growth, collagen secretion, and PLOD2 
expression. The collagen fibers that were secreted were also wider and longer then the 
control gels. The clinical relevance of these observation was determined by querying 
publically available TCGA global expression data. TCGA data was queried using GEPIA 
there was a direct correlation with PLOD2 expression and TGF-, SMAD2, or HIF1-  
in patient samples; as well as a dramatic decrease in patient survival in patients who had 
increased expression levels of PLOD2.  Finally, using this new hypoxic collagen gel 
platform the response of primary patient hUPS cells was displayed to be similar to what 
was predicated using the KIA line, demonstrating the ability for this platform to screen 
future therapeutics to minimize cancer progression. This is one of the first studies to 
study the effect of stress relaxation in regard to tumor growth and metastasis in a truly in 
vivo mimicking system. This platform can further be adapted to explore stress relaxation 




5.5 Supplementary Figures 
 
Supplementary Figure 5-1: Additional Mechanical Characterization of Hydrogel  
A.) Creep and recovery test was performed to demonstrate the relaxation time of the 
material after a constant stress was applied. B.) The relaxation time was calculated 
from the creep and recovery tests. C.)  A frequency sweep was performed on the 
hydrogels and the slope (D) of the line was calculated showing a difference in slope 
between the two materials. D.) A stress vs. strain curve was generated to identify the 








Supplementary Figure 5-2: Instantaneous Velocity Profiles:  
The velocity of KIA cells in the x,y,z direction as well as the speed was calculated for 
atmospheric (A) and hypoxic (B) gels C.) The percent alignment of collagen fibers 
within the different hydrogels.  
 
 
Supplementary Figure 5-3: Confounding factors for cell interaction with the matrix. 
Vinculin stain showed no difference in the four different hydrogels. Cytoskeletal 
actin also was similar in all four conditions. There was no nuclear localization of 
YAP in any of the four conditions. The amount of vinculin and actin filaments per 





Supplementary Figure 5-4: MMP expression of KIA cells in the different hydrogels. 
(A). PCR was used to quantify expression of MMP2 and MMP9. (B). Protease 
activity was measured using DQ assay of cells on day 2 (C). Cell morphology and 





Supplementary Figure 5-5: hUPS cell migration increases with the quicker stress 
relaxation time in hypoxia.  
A.) Representative photos of the hUPS cells in hypoxic and atmospheric hydrogels 
with two different stress relaxations. B.) Oxygen gradients on day three for the 
hypoxic and atmospheric hydrogels with hUPS cells. C.) The aspect ratio of the 
hUPS  cells D.) Migration of hUPS cells in the atmospheric hydrogels on day 3 
showing minimal difference in migration. E.) Migration of the hUPS cells in hypoxic 








Supplementary Figure 5-6: The velocity of hUPS cells in the x,y,z direction as well 
as the speed was calculated for atmospheric  






6 Thesis conclusions and future work 
 
6.1 Conclusions 
Oxygen gradients and mechanical cues are key pieces of the tumor 
microenvironment. Our goal was to create better in-vitro hydrogel models to control and 
mimic the tumor ECM and oxygen gradients. In Chapter 3 we report the impact of 
hypoxic O2 gradients on sarcoma cell invasion and migration. O2 gradient measurements 
showed that large sarcomas mouse tumors (>300mm3) contain a severely hypoxic core 
(≤0.1% pO2) whereas smaller tumors possessed hypoxic gradients throughout the tumor 
mass (0.1%-6% pO2). To analyze tumor invasion, we utilized O2-controllable hydrogels 
to recreate the physio-pathological O2 levels in vitro. Small tumor grafts encapsulated in 
the hydrogels revealed increased invasion that was both faster and extended over a 
longer-distance in the hypoxic hydrogels compared to nonhypoxic hydrogels. To 
accurately model the effect of the O2 gradient, we examined individual sarcoma cells 
embedded in the O2-controllable hydrogel. We observed that hypoxic gradients guide 
sarcoma cell motility and matrix remodeling through HIF–1α activation. We further 
found that in the hypoxic gradient, individual cells migrate more quickly, across longer 
distances, and in the direction of increasing O2 tension. Treatment with minoxidil, 
inhibitor of hypoxia-induced sarcoma metastasis, abrogated cell migration and matrix 




agent during sarcoma tumor invasion and propose the O2-controllable hydrogels as a 
predictive system to study early stages of the metastatic process and therapeutic targets. 
Secondly, in Chapter 4 we utilized an oxygen gradient collagen gel platform to 
determine the impact of collagen fiber density and hypoxic gradient on sarcoma cell 
migration.  The oxygen gradient was created by regulating the oxygen diffusion 
coefficient along with the cellular oxygen consumption rate. Collagen fiber density in the 
hydrogels is modified by changing the pre-incubation period of the collagen gel solution 
at 4C, controlling fiber density independently of collagen concentration and oxygen 
tension. High fiber density gels have a similar micro-scale pore size with a larger nano-
scale pore size and quicker stress relaxation time, compared to the low fiber density gel. 
Both gels have the same Young’s modulus. We analyzed responses of sarcoma cells 
encapsulated in the different hydrogels for three days. In the nonhypoxic low fiber 
density constructs, sarcoma cells exhibit larger aspect ratio and the ECM has less fiber 
alignment compared to the nonhypoxic high fiber density constructs. Interestingly, we 
found minimal effect of fiber density on cell migration and the ability of the cells to 
degrade the matrix in nonhypoxic constructs. When compared with hypoxic constructs, 
we observed the opposite trend, where cells in low fiber density constructs exhibit a 
lower aspect ratio and the matrix has more aligned fibers compared to hypoxic high fiber 
density constructs. Sarcoma cells encapsulated in high fiber density hypoxic gels 
migrated faster and degraded the matrix more rapidly compared to the low fiber density 
hypoxic constructs. Overall, we show that hypoxic cell migration and matrix degradation 
are enhanced in high fiber density gels, while hypoxic matrix alignment is prominent in 




hypoxic gradients are due the material architecture of the hypoxic hydrogel such as 
higher fiber density and stress relaxation. 
Finally, in Chapter 5 we created  a new hypoxic collagen gel platform that allows 
for oxygen gradients and stress relaxation to be controlled independently from each other. 
This new platform allows us to explore the effect of quicker stress relaxation in sarcoma 
cell migration and tumorigenesis via three dimensional (3D) cell motility, molecular 
biology, and in-vivo tumor growth. We conclude that stress relaxation in hypoxic 
gradients leads to an increase in cell migration along the gradient, an increase in PLOD2 
expression, as well as an increase in tumor growth. In addition stress relaxation is 
upregulating PLOD via TGF-. Also, when TCGA global expression studies were 
queried we find a significant decrease in patient survival with an increase in PLOD2 
expression. Finally, we were able to demonstrate the platforms ability to screen primary 
patient tissue which demonstrated a similar response as our mouse sarcoma cells. 
6.2 Suggestions for future works 
In recent years great advances in synthesis of hydrogel biomaterials and other 3D 
miniature devices have been explored for tissue regenerative applications, but have not 
yet been fully taken advantage of in the field of cancer research. For example, with recent 
advances in organ on a chip technologies, the next logical step is to make a tumor on a 
chip or to create more physiologically relevant diseases on a chip. For example, Huh and 
colleagues have developed a lung on a chip model, which can mimic the physiological 
environment of the lung[220]. The next step with this technology is to integrate cancer 
phenotypes in specific locations in the lung on a chip model, to mimic tumor metastasis. 




chip which are slowly transitioning into looking at intravasation or extravasation of tumor 
cells in/out of existing vasculature[221]. However the majority of these devices use a 
basis of collagen gels as the 3D hydrogel portion of the device. The next generation of 
these approaches, should incorporate more advanced materials to augment these natural 
ECM’s enabling more accurate mimicking of physiological relevant chemical and 
cytokine gradients.  
 These technologies will also have to further incorporate multiple cell types. As we 
have explored above, the tumor microenvironment is a complex combinations of ECM 
and multicellular cues. CAFs have been explored in their importance in tumor migration 
and ECM modification. Preliminary studies have been performed incorporating stromal 
cells into systems to study the change in cancer migration. In addition to CAFs role in 
augmenting the surrounding tumor ECM, they also change the barrier and structure of EC 
and vasculature. In order to culture multiple cell types that require different culture 
conditions and ECM components, a more complex patterning of hydrogels networks and 
matrixes needs to be developed for cancer research. Our lab have shown that one can 
control cancer and EC patterning solely via extracellular matrix proteins[222]. 
Technologies developed by Burdick and colleagues have shown the ability to take 
advantage of different properties of “self healing” and shear thinning gels to print 
controlled patterns that could be adapted for this multiple cell type and ECM co-culture 
platforms[223]. 
 However, the end goal with the majority of these complex systems is to discover 
new mechanisms in cancer development, growth and metastasis. However, due to the 




bioengineering fields. Classical biological researchers do not have the equipment to 
successfully perform these assays (i.e. 3D printers, syringe pumps, chemical equipment 
for biopolymer synthesis). Effort should be made to simplify the mode of operation to 
allow a friendly use. Moreover, these devices can be used for potential therapeutic 
evaluation and possible replacement of in-vivo studies. Such trials though complex, are 
still less expensive and more controllable than current in-vivo models. The ability to 
simplify the current technologies to be single or two component mixtures, would greatly 
enhance their translatability and wide spread use. If this could be accomplished, the 
transition from drug discovery to personalized medicine could be achieved.  
 Personalized medicine is a new and very exciting field in cancer research; 
however there are a few technologies that make the translatable jump from the bench top 
the clinic. Recently, Jonas et al demonstrated use of a very complex system in the clinic, 
which allows for the testing of up to sixteen different therapeutics in small micro-
doses[224].  In this device they created Delrin acetal resin blocks that could hold sixteen 
different therapies individually by controlling the drug release kinetics in the tumor 
microenvironment. The device is then implanted in mice in human tumors via a biopsy 
needle, and then is extracted via a corning needle and evaluated under histological 
analysis. More technologies like this need to be adapted to either be usable in a clinical 
setting, or more importantly, over a wide variety of cancer cell types. Other challenges 
include the inherit heterogeneity nature of the tumor with wide variety of genomic 
changes and the ability to keep tumor samples alive outside the body. Finally, in addition 
to the biological challenges, wide application use and ease of use of these advanced tissue 




researches across disciplines to access the latest technologies.  Mass production will 
further require a better definition of fabrication and synthesis parameters for specific or 
general use. This may fulfill the need for truly controllable and reproducible systems that 
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